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1 Introduction 
1.1 Mycobacteria 
Mycobacterial pathogens present a health threat worldwide with Mycobacterium  
tuberculosis (Mtb) alone accounting for 1.3 million deaths and 8.6 million new and relapse 
infections in 2012 (http://www.who.int/tb/publications/global_report/en/). Tuberculosis is an 
infectious bacterial disease caused by the facultative intracellular pathogen Mycobacterium 
tuberculosis that is still posing a major health and socio-economic burden at a global level, 
primarily in low and middle-income countries. The genus Mycobacterium includes more 
than 60 species and more than 100 sub-species (http://www.dsmz.de). Currently a number of 
8 species are referred to as the Mycobacterium tuberculosis complex (M. tuberculosis, M. 
bovis (including the BCG strain), M. africanum, M. microti, M. canettii, M. caprae, M. 
pinnipedii, M. mungi) and all of these can cause the clinical picture of tuberculosis. M. 
tuberculosis and  M. leprae were recognized as pathogenic for humans only about 140 years 
ago and their pathogenic behaviors have been studied extensively. Mycobacteria other than 
M. tuberculosis and M. leprae, are called non-tuberculous mycobacteria (NTM) or 
mycobacteria other than tuberculosis (MOTT) and about 20 species of them cause human 
and animal diseases (Heifets, 2004). NTM species are ubiquitous in the environment, 
predominantly populating soil and water (Falkinham, 2010, 2002; Taylor et al., 2000). They 
have been recovered from surface water, tap water, soil, domestic and wild animals, milk, 
and food products (Thomson et al., 2007). The incidence of infection and disease due to non-
tuberculous mycobacteria (NTM) is rising in many countries. It was thought that NTM are 
more prevalent in tropical countries (Africa and Australia), however, accumulation of recent 
data suggests that it is also prevalent in temperate countries like USA, Canada, Germany, 
United Kingdom and China (Behr, 2008; Thomson, 2010). 
NTM and specifically M. avium became inevitably recognized as pathogens causing severe 
diseases in humans at the beginning of the HIV/AIDS era. Back then M. avium caused 
severe, mostly fatal infections in immuno-compromised patients. The most prominent risk 
factors for the development of disseminated M. avium infection were a CD4 cell-count of 
less than 100/ml and previous colonization of mucosal surfaces with M. avium (Horsburgh, 
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1991; Klatt et al., 1987; Mapother and Songer, 1984; Nightingale et al., 1992). Although 
there is a strong correlation between M. avium disease and low CD4 cell-counts, a specific 
immune defect facilitating invasion and dissemination of M. avium has not yet been defined. 
Uptake and intracellular growth inhibition of M. avium by monocytes derived from AIDS 
patients has been shown to be normal in vitro. Moreover, the application of granulocyte 
colony stimulating factor G-CSF, a cytokine that specifically activates neutrophils was 
beneficial with regard to survival of AIDS patients suffering from M. avium infection 
(Keiser et al., 1998). This implicates that neutrophils may have a protective role in M. avium. 
Moreover, there are reports showing that M. avium and other NTM cause lung infection 
(also called atypical mycobacterial pulmonary infections) in immuno-competent individuals 
(Piersimoni and Scarparo, 2008; Taiwo and Glassroth, 2010). Also, epidemiologic 
surveillance reveals that the occurrence of NTM diseases is increasing in industrialized 
nations where TB transmission is low and where BCG vaccines are not given (Lietman et 
al., 1997; Winthrop et al., 2010). The incidence of NTM infections is particularly increasing 
in the elderly (Mirsaeidi et al., 2014), most of them exhibiting pulmonary infection caused 
primarily by M. avium. Some of these lung infections occur as a complication of pre-existing 
lung disease, such as bronchiectasis and chronic obstructive pulmonary disease. However, 
some other infections occur in healthy hosts without pre-existing lung disease or overt 
immunologic disorder (Huang et al., 1999; Koh et al., 2002; Marras et al., 2013; Sadek et al., 
2008; Thomson, 2010). Generally, non-tuberculous mycobacteria (NTM) inhabit body 
surfaces and secretions without causing disease. However, under certain conditions, which 
are not fully understood, they can induce some clinical manifestations such as progressive 
pulmonary disease, superficial lymphadenitis, disseminated disease, and skin and soft tissue 
infection. Disseminated disease can occur in severely immuno-compromised patients 
(Griffith et al., 2007). 
 
Among NTM species, M. avium attracts serious attention, as is the most common cause of 
non-tuberculous pulmonary disease worldwide. This species includes four subspecies: M. 
avium avium (MAA), M. avium hominissuis (MAH), M. avium paratuberculosis (MAP) and 
M. avium silvaticum (MAS) (Thorel et al., 1990; Turenne et al., 2008). MAA and MAS are 
specific avian pathogens causing a tuberculosis-like disease in birds (Dvorska et al., 2003). 
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MAP is a well-known pathogen causing Johne’s disease (Harris and Barletta, 2001) and may 
have a role in human Crohne’s disease (Feller et al., 2007). Of importance, MAH causes 
pulmonary infections in humans in which the normal T cell immunity is compromised. 
 
1.2 Pathogenesis 
Virulent mycobacteria reside in the phagosomes in infected macrophages and prevent killing 
by blocking the phago-lysosome fusion (Danelishvili et al., 2007; Rocco and Irani, 2011; 
Russell, 2013). This ability of virulent mycobacteria to survive and multiply in macrophages 
is considered as the key for their pathogenicity, latency and transmission. All virulent 
mycobacteria like Mtb, M. bovis, M. avium and M. marinum dwell in macrophages by 
modifying the phagosome, the most hostile environment, according to their requirements, 
which is the signature evasion mechanism of virulent mycobacteria (Danelishvili et al., 
2007; Early and Bermudez, 2011; Rocco and Irani, 2011; Russell, 2013).  
Despite the differences between M. avium and Mtb, the basic pathogenic behavior in 
promoting their survival in infected macrophages, the primary host cell is similar. M. avium 
invades the human host via either the respiratory tract or the intestinal epithelium: the latter 
route of infection rather causes rapid dissemination than the former. M. avium interacts with 
various receptors to gain access into the macrophages. Macrophages express an array of 
pathogen recognition receptors (PRRs) and phagocytic receptors that play a crucial role in 
their recognition and response to pathogens. For example complement receptors (except, 
CR3 and CR4) (Bermudez et al., 1999; Bohlson et al., 2001), mannose receptors, fibronectin 
(Bermudez et al., 1991; Polotsky et al., 1997), and type A scavenger receptors are involved 
in this process. Also toll-like receptors (TLRs) 2 and 9 are important for M. avium 
recognition (Appelberg, 2006; Feng et al., 2003; Gomes et al., 2004; Gomes et al., 2008). 
This recognition leads to the phagocytosis of pathogens and the resulting combinatorial 
signals from these receptors are important for the activation of macrophages and thereby, are 
essential for the initiation of the innate immune response (Akira et al., 2006; Schafer et al., 
2009; Takeuchi and Akira, 2010). Once, they are phagocytized by macrophages, they reside 
in a plasma membrane derived intracellular vesicle called phagosomes. Microorganisms in 
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the phagosomes are killed and digested upon fusion with lysosomes in their maturation 
process, forming phago-lysosomes (Desjardins et al., 1994; Vieira et al., 2002). Similar to 
other pathogenic mycobacteria, M. avium inhibits phagosome maturation, by preventing 
acidification and by blocking fusion of phagosomes with extremely acidic lysosomes 
(Danelishvili et al., 2007; de Chastellier and Thilo, 2002). 
Efficient killing of pathogens in macrophages requires distinct pro-inflammatory cytokines. 
Once the macrophage engulfs M. avium, it produces and secretes numerous chemokines, 
cytokines and their ligands, e.g. TNF- α, LT-a/b; IL-1, -6, -12, -18; G-CSF and GM-CSF; 
CXCL-1, -2, -3, -8; CCL-2, -3, -4, -5, -20 (Blumenthal et al., 2005; Sarmento and 
Appelberg, 1996; Shiratsuchi and Ellner, 2001) which induce the development of pro-
inflammatory responses. It has been shown that infection of macrophages with various 
mycobacteria strain types induce a differential pattern of cytokines in vitro (Chacon-Salinas 
et al., 2005). 
It is evident that activation of TLR 2/MAPK leads to activation of immune response in 
macrophages. Subsequent activation and nuclear translocation of NF-kB occurs, which 
greatly enhances mycobacterial killing by production and secretion of pro-inflammatory 
cytokines, and facilitating phago-lysosome fusion (Gutierrez et al., 2008; Pathak et al., 
2004). Interference with the activation of toll-like receptors (TLRs), in activation of host 
antimicrobial responses possibly by surface molecules may promote their survival in the 
macrophages (Early and Bermudez, 2011). A substantial amount of evidence indicated that 
cell wall glyco-peptidolipids (GPLs) are responsible for pathogenesis and specific GPLs are 
associated with virulence (Bhatnagar and Schorey, 2006). The protective responses against 
M. avium largely depend upon activation of macrophage oxidative/bactericidal functions by 
type 1 pro-inflammatory cytokines provided by immune T lymphocytes and other cell types 
(Ehlers et al., 2000; Florido et al., 2005; Petrofsky and Bermudez, 2005). In vitro studies and 
animal infection models have shown that phylogenetically diverse mycobacteria strains 
exhibit markedly different virulence and pathogenesis phenotypes in macrophages (Early 
and Bermudez, 2011; Lopez et al., 2003; Manabe et al., 2003; Manca et al., 2004; Manca et 
al., 2001; Meyer et al., 1998; von Reyn et al., 1995). 
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Though, M. avium is not considered as a public health problem, it is increasingly recognized 
as a relevant pathogen due to its overall increasing incidence not only in patients with 
immunosuppression, but also in immuno-competent individuals and its high case fatality 
(Henry et al., 2004; Marras and Daley, 2002; McGrath et al., 2008). Studying M. avium 
biology and pathogenesis is important because its clinical appearance and relevance 
(Chatterjee and Khoo, 2001; Rocco and Irani, 2011) is supposedly interlinked with the 
mechanisms by which some species of the genus are pathogenic while others are not (Behr, 
2008; Grubek-Jaworska et al., 2009). The in vitro virulence of M. avium isolates obtained 
from various sources is characterized by determining their ability to multiply in primary 
human monocyte derived macrophages. We have previously systematically characterized M. 
avium human clinical isolates and environmental isolates based on their ability to replicate in 
human macrophages. Along this study we found that the macrophage-induced gene (mig) is 
quite consistently expressed when the bacilli are growing within macrophages making it a 
potential marker for clinical pathogenicity and in vitro virulence of M. avium isolates (Meyer 
et al., 1998; Plum and Clark-Curtiss, 1994). Analyses of growth rate of these isolates in 
macrophages suggested that the in vitro virulence of these isolates vary at length between 
and among clinical and environmental isolates. From the panel of those previously 
characterized strains we have chosen SCH 228 as a strain that exhibited a fast growth rate in 
macrophages (≈ 18 h) and SCH 215 which was only slowly replicating in macrophages in 
order to characterize their interaction with neutrophils. 
 
1.3 Mycobacteria and neutrophils 
Neutrophils are typically the first responders in host defense against invading pathogens. 
Neutrophils destroy pathogens by both oxidative and non-oxidative mechanisms. They are 
recruited to the site of mycobacterial infection and are the most predominantly infected 
phagocytic cells in human tuberculosis (Eum et al., 2010).  However, the role of neutrophils 
in mycobacterial infection is not fully understood. There is clinical evidence based on the 
beneficial impact of the application of G-CSF on survival of AIDS patients suffering from 
M. avium infection (Keiser et al., 1998). Martineau et al. (2007) showed that neutrophils 
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contribute significantly to the control of Mtb in human blood. Some earlier murine studies 
reported a protective role for neutrophils in early infection with Mtb as well as with M. 
avium (Barrios-Payan et al., 2006; Pedrosa et al., 2000; Sugawara et al., 2004). On the 
contrary, a study showed that neutrophils do not contribute to the control of Mtb (Seiler et 
al., 2000). Furthermore, a neutrophil-driven, interferon (IFN)-inducible transcript signature 
in human whole blood was recently identified that correlated with clinical severity of TB, 
raising the possibility that neutrophils may directly contribute to disease pathogenesis (Berry 
et al., 2010). Similar to macrophages, neutrophils have been shown of being capable to 
phagocytize and kill at least some mycobacterial species. However, a systematic analysis of 
the cell-autonomous immune regulation of human neutrophils upon infection with human 
clinical M. avium hominissuis isolates was not undertaken so far. Moreover, it is widely 
accepted that only a better understanding of the pathogenic processes associated with M. 
avium infection and disease will lead to the development of effective tools to control these 
conditionally pathogenic bacteria. 
 
1.4 Inhibition of phago-lysosomal fusion  
Macrophages express an array of pathogen recognition receptors (PRRs) and phagocytic 
receptors that play a crucial role in their recognition and response to pathogens. Many 
studies have shown that receptors such as Toll-like receptors (TLR-2, 4, 6 and 9) (Heldwein 
and Fenton, 2002; Jo et al., 2007; Means et al., 1999; Quesniaux et al., 2004) mannose 
receptors (McGreal et al., 2005), DC-SIGN, Dectin-1, and Mincle (Torrelles et al., 2006), 
the complement C3 receptors, Fcγ phagocytic receptors, CD-14 and NOD-like receptors 
(NLRs) are involved in the recognition process. This recognition leads to the phagocytosis of 
pathogens and the resulting combinatorial signals from these receptors are important for the 
activation of macrophages and thereby, are essential for the initiation of the innate immune 
response (Akira et al., 2006; Schafer et al., 2009; Takeuchi and Akira, 2010).  
Phagocytosis of invading bacteria by professional phagocytes such as macrophages, DCs 
and neutrophils results in the formation of a plasma membrane derived intracellular vesicle 
around the pathogen. This newly formed cellular compartment is called phagosome in which 
pathogenic microorganisms are killed and digested upon fusion with lysosomes in their 
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maturation process, forming phago-lysosomes. After detachment from the host cell 
membrane, a nascent phagosome undergoes a series of progressive maturation processes 
involving fission and fusion events that modify the composition of the membrane. This 
process highly depends on the interaction of the phagosome with the endocytic pathway; 
phagosomes sequentially fuse with early (sorting) endosomes, late endosomes, and 
eventually with lysosomes (Desjardins et al., 1994; Vieira et al., 2002).  This process enables 
nascent phagosomes to gradually acquire the properties of the donor organelles, including 
the distinct membrane markers and the increasingly acidic pH value. As a consequence, a 
phagosome ultimately matures into a hybrid intracellular compartment called phago-
lysosomes. Phago-lysosomes contain various digestive enzymes, including proteases, 
nucleases, lipases, and β-galactosidases, which display optimal activities in the highly acidic 
condition (pH ≤5.0) and efficiently degrade luminal contents (Vieira et al., 2002) 
However, during Mtb infection, the phagosome maturation pathway is altered via multiple 
mechanisms to disrupt normal phagocyte effector functions (Deretic et al., 2006; Russell, 
2001). The early maturation process of the Mtb phagosome includes fusion with early 
endosomes, wherein both Rab5 and transferrin receptors are found associated with it. 
However, the pathogen prevents recruitment of Rab5 effector proteins, such as early 
endosomal auto antigen 1 (EEA1) and hVPs35 (Fratti et al., 2001) that are required for 
further maturation of the phagosome. Absence of Rab5 effector proteins on Mtb phagosomes 
prevents docking and delivery of lysosomal hydrolases, cathepsins, and vacuolar ATPases. 
Ultimately, these defects result in a failure in conversion of a Rab5 (an early endosomal 
marker) containing phagosome to a Rab7 (a late endosomal marker) containing phagosome 
(Via et al., 1997). 
 
1.5 Regulation of cytokines 
Efficient killing of pathogens in macrophages require adequate and appropriate pro-
inflammatory cytokines. Macrophages produce pro-inflammatory cytokines and chemokines 
in order to mount effective immune response against pathogens. Once the macrophage 
engulfs Mtb, it produces several cytokines such as IL-2, IFN-γ, IL-6, IL-1α/β, IL- 12, and 
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TNF-α (Kellar et al., 2011) and chemokines including CCL2, CCL3, CCL5, CCL7, CCL12, 
CXCL2, CXCL8, and CXCL10 (Algood et al., 2003), which induce the development of pro-
inflammatory responses. Release of these chemokines is associated with activation of 
microbicidal responses promoting the migration of different cell subpopulations towards the 
Mtb-infected tissues to form granulomas (Serbina et al., 2008). Several studies have 
investigated the effects of chemokines in the function and recruitment of monocytes 
following the infection with Mtb. They promote monocytes, DCs, activated macrophages, 
polymorphonuclear cells (particularly neutrophils), and T lymphocytes migration to 
bronchoalveolar spaces during pulmonary TB (Gonzalez-Juarrero et al., 2003). 
Mycobacteria are endowed with the unique capacities to modulate fundamental 
inflammatory processes, such as recruitment of immune cells to the infected lung and 
production of critical pro-inflammatory cytokines, including tumor necrosis factor-α (TNF-
α), interleukin-1β (IL-1β) and interferon-γ (IFN-γ). In addition, mycobacteria interfere with 
biochemical pathways involved in the production of eicosanoids and other lipid mediators 
that affects the fate of the infected cells. Many studies have shown that infection of 
macrophages with various Mtb strain types induce a differential pattern of cytokines in vitro 
(Chacon-Salinas et al., 2005). Recently, in vitro studies and animal infection models have 
shown that phylogenetically diverse Mtb strains exhibit markedly different virulence and 
pathogenesis phenotypes in macrophages (Lopez et al., 2003; Manabe et al., 2003; Manca et 
al., 2004; Manca et al., 2001).   
 
1.6 ROS production 
Production of reactive nitrogen intermediates (RNI) and reactive oxygen species (ROS) are 
one of the killing mechanisms in macrophages. The rapid generation of ROS is critical for 
host defense against bacteria and fungi. In addition to its ability to kill pathogens, ROS has 
broad signaling functions (Kumar et al., 2011). The NADPH oxidase family protein 
complexes generate ROS and are the main sources of ROS both in activated neutrophils and 
macrophages. The early events in Mtb infection involve the phagocytosis of the bacilli by 
alveolar macrophages and often their immediate killing by different macrophage bactericidal 
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mechanisms, including RNI and ROS (Zuniga et al., 2012). 
 
1.7 Neutrophils  
Polymorphonuclear neutrophils (PMNs) are the most abundant white blood cells in the 
human circulation. They are key components of the first line of defense against bacterial and 
fungal pathogens, and they also participate in the development of the inflammatory reaction 
(Nathan, 2006). For long time, it was thought that neutrophils are short lived and die soon 
after their antibacterial function. Discoveries during the 1990s and early 2000s made 
immunologists to appreciate the amazing complexity and sophistication of neutrophil 
functions. It became evident that neutrophils release various cytokines and chemokines and 
contribute to orchestrating the immune/inflammatory response (Cassatella, 1995). Highly 
sophisticated machinery directing neutrophil migration (Nourshargh et al., 2010) and a 
complexity of neutrophil granules (Borregaard et al., 2007) also came to be known. In 
addition, the concept that release of granular contents (Reeves et al., 2002) and formation of 
neutrophil extracellular traps  (NETs) (Brinkmann et al., 2004) are involved in the killing 
mechanisms of neutrophils underscored the fact that neutrophils use complex mechanisms to 
perform their immune defensive functions (Amulic et al., 2012; Mantovani et al., 2011; 
Nathan, 2006). In the past few years, scientists have witnessed the novel roles of neutrophils 
in immunity against intracellular pathogens such as viruses and intracellular bacteria; 
shaping of adaptive immunity at different levels; and roles in diseases such as allergy and 
anaphylaxis, metabolic diseases, atherosclerosis, or thrombus formation. Approaches like 
antibody (anti-Gr1 or anti-Ly6G)-mediated depletion of neutrophils in mice (Daley et al., 
2008) or genetic manipulations leading to the partial or complete genetic deletion of the 
neutrophil lineage (Hock et al., 2003; Jonsson et al., 2005; Ordonez-Rueda et al., 2012) 
helped to understand the role of neutrophils in immunity.  
 
1.8 Neutrophil reservoirs 
Under physiological conditions, nearly 50% of the circulating neutrophils are mature pool of 
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granulocytes. These neutrophils can be found in the bone marrow, spleen, liver and lung 
(Summers et al., 2010). The lung seems to be enriched in mature neutrophils than other 
organs (Kreisel et al., 2010; Sibille and Marchandise, 1993).  However, it is not clearly 
understood how and why neutrophils are concentrated within these organs. One explanation 
could be that these organs are reservoirs of mature neutrophils, which can be rapidly 
deployed to sites of inflammation or infection. However, it is also possible that neutrophils 
are constantly patrolling in these organs in search of tissue damage or microbial invasion. 
 
1.9 Maturation of neutrophils 
Neutrophils are continuously generated in the bone marrow from myeloid precursors, a 
process called terminal granulocytopoiesis. Their daily production can reach up to 2 × 10
11 
cells (Borregaard, 2010). Interleukin‐17A (IL‐17A) synthesized by T cells induces 
granulocyte colony stimulating factor (G‐CSF), which in turn controls this maturation 
process of neutrophils (Ley et al., 2006). Release of IL‐17A is in turn under the control of 
IL‐23 originating from tissue‐resident macrophages and dendritic cells. During inflammation 
the number of neutrophils that infiltrate in tissues increases, and these pathogen-induced 
apoptotic cells are removed by macrophages and dendritic cells. This neutrophil clearance 
process results in down regulation of IL‐23 synthesis by those cells and thus reduces G‐CSF 
release (Stark et al., 2005). During maturation, the neutrophil goes through several stages, 
namely myeloblast, promyelocyte, myelocyte, metamyelocyte, band cell and, finally, 
polymorphonuclear (segmented) cell. The different subsets of granules such as azurophilic, 
specific granules, and gelatinase granules and secretory vesicles are formed sequentially 
during maturation from promyelocytes (Borregaard, 2010). 
 
1.10 Neutrophil migration 
Neutrophils are the first responders to inflammatory stimuli such as bacterial infection or 
tissue injury and this requires migration from the circulation to the site of inflammation. In 
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the resting state, neutrophils are poorly adherent and exist in a spherical shape. A rapid 
change in cell morphology occurs in response to inflammatory stimuli such as formyl-Met-
Leu-Phe (fMLP), IL-8 or bacterial products and become polarized and migrate towards the 
inflammatory mediators. Migration of neutrophils involves many well-coordinated 
interactions with vascular endothelium. This can be divided into four steps; capture, rolling, 
arrest and trans-endothelial migration (TEM). 
Initiation of migration begins with the “capture” of PMNs by the vessel wall from flowing 
blood followed by their “rolling” along the vessel wall. This process of margination is a 
normal behavior of circulating PMNs. However, when appropriate stimuli are sensed, rolling 
of neutrophil comes to a halt and neutrophils become firmly attached to ECs. Both the 
process of capture and rolling is due to the reversible binding of transmembrane glycoprotein 
adhesive molecules called selectins, which are found on both PMNs and ECs. L-selectin 
expressed on the surface of neutrophils, allows loose tethering for the latter to roll along the 
endothelium. that later induces conformational changes in integrin adhesion molecules 
expressed on endothelial cells which results in strong adherence and leading to rolling arrest. 
Rolling arrest can also be mediated by binding of chemoattractants such as IL-8 to 
neutrophil receptors.  
It has been postulated that TEM is initiated by either a receptor- mediated event in response 
to an inflammatory cytokine or an event propagated from signals from activated selectins. 
Down-regulation of selectins induces expression of integrins such as platelet-endothelial cell 
adhesion molecule-1 (PECAM-1) in a timely and sequential manner, which finally leads to 
the successful migration (Woodfin et al., 2009). Migration of neutrophils through endothelial 
cells to an inflamed site is guided by a chemotactic gradient. For example the exposure of 
neutrophils to chemoattractants such as fMLP and complement component 5a (C5a) induces 
cellular polarization of chemoreceptors and formation of actin-rich pseudopodia at the 
leading edge of the cell (Servant et al., 2000). Adhesion and migration of neutrophils are 
accompanied by release of proteases and receptors upon degranulation (Hanlon et al., 1991). 
PMNs possess proteases capable of digesting collagen, laminin, and other extracellular 
components present in the vascular wall for the efficient migration towards the source of 
chemoattractants or the site of infection. 
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1.11 Activation of neutrophils 
In the circulation of healthy adults, neutrophils exist in a resting state, which ensures that 
their toxic intracellular contents are not accidentally released to damage host tissue. 
Activation or priming of neutrophils occurs via two separate mechanisms. Resting 
neutrophils can become rapidly primed when intracellular granules possessing preformed 
receptors are mobilized to the plasma membrane. This rapid process enhances the number of 
plasma membrane receptors by mechanisms that do not require protein synthesis. However, 
often, neutrophils can become primed by agents that include bacterial products and cytokines 
or chemokines, e.g. TNF-α, GM-CSF, IL-8 and IFN-γ (Hallett and Lloyds, 1995) and primed 
neutrophils are then mobilized to the site of infection or inflammation, where they encounter 
activating signals to trigger bacterial killing. 
 
1.12 Recognition of pathogens 
It has long been known that N-formyl peptides induce neutrophil chemotaxis and functional 
activation via the seven-transmembrane G protein-coupled receptor FPR1. The production of 
formylated proteins is restricted to bacteria and mitochondria (Zhang et al., 2010), and 
therefore FPR1 fulfills the criteria of a pattern recognition receptor (PRR) recognizing 
microbial moieties and tissue damage. Neutrophils express a vast repertoire of PRRs 
including all members of the Toll-like receptor (TLR) family with the exception of TLR3 
(Hayashi et al., 2003); the C-type lectin receptors dectin 1 (Greenblatt et al., 2010) and 
CLEC2 (not expressed in mouse neutrophils) (Kerrigan et al., 2009) and cytoplasmic sensors 
of ribonucleic acids (RIG-I and MDA5) (Tamassia et al., 2008). In addition, neutrophils 
express nucleotide-binding oligomerization domain protein 1 (NOD1) (Clarke et al., 2010), 
although the expression and function of the NOD-like receptors (NLRs) that are components 
of the inflammasome have not been carefully studied. The sensing of pathogens and tissue 
damage through these PRRs, together with lymphoid cell-derived signals, activates the 
effector functions of neutrophils. These include the production of reactive oxygen 
intermediates (ROI), lytic enzymes and antimicrobial peptides, and release of NETs (Segal, 
2005). 
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1.13 Killing mechanisms 
Neutrophils can eliminate both intra- and extracellular pathogens by multiple mechanisms. 
When neutrophils encounter microorganisms, they phagocytize, encapsulate them in 
phagsomes, and kill the pathogens using NADPH oxygenase-dependent mechanisms and/or 
antibacterial proteins released into the phagsomes from various granules (Borregaard, 2010; 
Hager et al., 2010). Soon after phagocytosis of the pathogen, contents of granules, especially 
specific and azurophilic granules fuse with the phagosomes. Upon further activation of 
neutrophils, accumulation of granular contents increases tremendously leading to the bulging 
of phagosomes. As a result of this accumulation and pumping in of various ions, the pH of 
the phagosome starts to decrease, which induces the fusion of lysosomes. Acidified 
condition of phagosomes is required for the phago-lysosomal fusion and for the optimal 
activity of various acid hydrolases and other contents of lysosomes in order to destroy 
pathogens. Neutrophils have developed a combinatorial mechanism, which involves granular 
contents and ROS to kill pathogens that have escaped from the oxidative mechanism of 
killing (Nordenfelt and Tapper, 2011; Winterbourn et al., 2006; Winterbourn and Kettle, 
2013). 
 
1.14 NADPH oxygenase-dependent killing mechanism 
Oxygen radicals and their reaction products, collectively referred to as ROS, are produced as 
a consequence of NADPH oxidase activity, which pumps superoxides (O-2, H2O2 and .OH-) 
into the phagocytic vacuole. The neutrophil NADPH oxidase system present mainly on the 
membrane of phagosomes and also on the plasma membrane is dormant in resting cells. 
When activated by soluble mediators (e.g., chemoattractant peptides and chemokines) and 
particulate stimuli (e.g., bacteria and immune complexes) it further interacts with cell-
surface receptors to generate copious amount of ROS. Activation of phagocyte NADPH 
oxidase (NOX2) is mediated by the assembly of cytosolic subunits (p40phox, p47phox, and 
p67phox) with the membrane subunits (p22phox and gp91phox). Phosphorylation mediated 
activation of p47phox by protein kinases allows its membrane translocation and binding to 
p22phox. On the other hand activation of Rac promotes its membrane translocation and its 
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binding to p67phox , finally leading to the assembly of active NOX2 and superoxide anion 
production. Accumulation of superoxide can cause damage to the cells. However, cells have 
scavengers and anti-oxidant mechanisms to convert this superoxide into H2O2. Apart from 
ROS, hypochlorous acid (HOCl), that is a potent anti-microbial agent known for decades, is 
also produced in phagosomes. Myeloperoxidases of azurophilic granules fuse with the 
microbe-containing phagosomes containing ROS, where halides are also pumped in. These 
myeloperoxidases then catalyze the H2O2-dependent oxidation of halides forming HOCL. 
 
1.15 Degranulation 
The granule proteins of neutrophils are key effectors in the immune response and are 
released   either into phagosomes or into the extracellular milieu, thus acting on either intra‐ 
or extra-cellular pathogens, respectively (Chertov et al., 2000). These proteins are essential 
for neutrophil-endothelial interaction, extravasation, phagocytosis, and elimination of 
microorganisms. Neutrophils contain four different granule subsets that are mobilized by 
stimulation and fuse with the cell or phagosomal membrane, resulting in exocytosis and/or 
exposure of soluble (present in their lumen) and membrane bound proteins. These granules 
are: azurophilic (also known as primary), specific (also known as secondary), gelatinase 
(also known as tertiary) and secretory granules (Faurschou and Borregaard, 2003). These 
classes of granules are formed sequentially during different stages of neutrophil 
differentiation in the bone marrow. The granules are classified according to their protein 
content and their differential ability to be exocytosed after neutrophil activation by 
inflammatory stimuli or phagocytosis of invading microorganisms. For example, secretory 
granules are more readily exocytosed than gelatinase granules, which in turn are more easily 
exocytosed than specific granules. Azurophilic granules only undergo limited exocytosis and 
are traditionally believed to contribute mainly to the intracellular degradation of 
microorganisms in the phago-lysosomes. These granules can be distinguished by their 
granule specific markers. Azurophilic granules contain high amounts of lysosomal enzymes 
(Faurschou and Borregaard, 2003) and are characterized by the presence of granulophysin 
(CD63) in their membranes (Cham et al., 1994). Their contents include myeloperoxidase 
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(MPO), bactericidal permeability-increasing protein, defensins, cathepsin G (a family of 
serine proteases) neutrophil elastase and proteinase 3. About one third of the total lysozyme 
is found in these granules (Baggiolini et al., 1969). 
 
Peroxidase-negative granules can be divided into specific and gelatinase granules (Kjeldsen 
et al., 1992b). Gelatinase granules are the main reservoir of tissue-degrading enzymes, such 
as metalloproteinase and membrane receptors needed during PMN extravasation and 
diapedesis (Mollinedo et al., 1997).  In contrast, specific granules participate mainly in the 
antimicrobial activities of the PMNs by mobilization of their arsenal of antimicrobial 
substances (e.g. alkaline phosphatases, collagenases, lactoferrin, NGAL, lysozyme, and 
hCAP18, the proform of LL-37) either to the phagosome or the exterior of the cell (Kjeldsen 
et al., 1992a; Mollinedo et al., 1997; Sengelov et al., 1995). These specific granules also 
contain unsaturated lactoferrin (that binds and sequesters iron and copper), neutrophil 
gelatinase-associated lipocalin and a number of membrane proteins including 
flavocytochrome b558 of the NADPH oxidase (Segal and Jones, 1979). The membrane of 
the gelatinase and specific granules contain markers such as CD66, CD15, or CD67. 
Secretory granules or vesicles are of endocytic origin that constitutes the main reservoir of a 
pool of membrane-associated receptors. Receptors stored in these vesicles are essential for 
neutrophil activation/function and are released easily in response to inflammatory molecules. 
These receptors are incorporated into the plasma membrane after release of the vesicles 
(Sengelov et al., 1994). For example, receptors such as β2-integrins, CR1, formyl peptide 
receptors (fpr), CD14, CD16 and the metalloproteinase leukolysin are displayed on the 
surface of neutrophils. This type of vesicle can be identified by the presence of their marker, 
CD35. 
 
1.16 NETs 
Neutrophils have developed specialized mechanisms to fight pathogens both in static and 
under in vivo flow conditions. Neutrophils have been shown to release their DNA, forming a 
net-like trap called neutrophil extracellular traps (NETs) that trap various bacteria 
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(Brinkmann et al., 2004). The process of formation of NETs is called NETosis. NETs are 
composed of nuclear components (such as DNA and histones) and are decorated by proteins 
from primary granules (such as myeloperoxidase and neutrophil elastase), secondary 
granules (such as lactoferrin and pentraxin 3 (PTX3)) and tertiary granules (such as matrix 
metalloproteinase 9 (MMP9) and peptidoglycan recognition protein short (PGRP-S). NET-
localized molecules have a diverse repertoire of functions, including microbial recognition, 
antimicrobial activity and tissue remodeling. Also, NETs were found to have pro-
inflammatory role (Gupta et al., 2010). 
 
1.17 Production of inflammatory mediators 
In response to a variety of inflammatory stimuli and pathological situations, primed 
neutrophils synthesize and secrete a panel of cytokines, chemokines, leukotrienes and 
prostaglandins.  These secreted cytokines not only activate themselves but also activate other 
cells of the immune system. Activated neutrophils have been reported to secrete cytokines 
(interleukin (IL)-1β, IL-1RA, IL-4, IL-6, IL-10, IL-12, transforming growth factor-β (TGF-
β), tumor necrosis factor-α (TNF-α), interferon-γ (IFN-γ)) and chemokines (IL-8 and 
interferon inducible protein 10 (IP-10)) (Cassatella, 1999). The secretion of various 
cytokines and chemokines by activated PMNs is regulated by immunoregulatory cytokines 
such as interferon gamma (IFN-γ), IL-4 and IL-10. Neutrophils also secrete leukotriene B4 
(LTB4) and prostaglandin E2 (PGE2), which are synthesized from arachidonic acid by 
lipoxygenases and cyclo-oxygenases, respectively.  
 
1.18 Neutrophil and macrophage interaction 
Being a fast responder, neutrophils are instrumental for both innate and adaptive immunity. 
After reaching the site of infection, they get activated by host and bacterial stimuli and 
release their mediators to attract and activate other innate immune cells like, macrophages, 
monocytes, epithelial cells, mast cells, endothelial cells and platelets, etc. In spite of their 
similar capacities such as phagocytosis of invading pathogens and immuno-modulatory 
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properties, both macrophages and neutrophils work as partners complementing and 
cooperating with each other (Silva, 2010b). It is thought that neutrophils that arrive to the 
site of infection first release macrophage inflammatory protein-1α (MIP-1α) and MIP-1β to 
attract monocytes and macrophages (Bennouna et al., 2003). In addition, release of (IFN)-γ 
from activated neutrophils causes activation of macrophages.  
Macrophages, by releasing TNF-α, IL- 1β, G-CSF and GM-CSF at the site of infection 
increase survival of recruited neutrophils (Lee et al., 1993; Yamashiro et al., 2001). 
Recently, it has been reported that macrophages release exosomes to communicate with 
other immune cells. Exosomes are small vesicles formed within multi-vesicular bodies 
(MVB) and are released outside the cell upon fusion of MVB with plasma membrane 
(Chaput and Thery, 2011; Robbins and Morelli, 2014; Schorey and Bhatnagar, 2008; Thery 
et al., 2001; Thery et al., 2002). Also, it has been proposed that exosomes that are released 
from the infected macrophages may have different roles depending upon the contents they 
carry (Robbins and Morelli, 2014). 
By virtue of their cell mediators, it is possible for activated neutrophils to influence 
macrophage differentiation into pro-inflammatory or anti-inflammatory subtypes (Chertov et 
al., 1997; Tsuda et al., 2004). Granular proteins especially myeloperoxidases from the 
neutrophils leads to the induction of reactive oxygen species (ROS) along with other pro-
inflammatory cytokines (i.e. TNF-α, IL-1, IL-6, IL-8 and GM-CSF) from macrophages 
(Ethuin et al., 2004; Lefkowitz et al., 2000). The interaction in the form of congregation of 
neutrophils and macrophages has been reported in many infectious diseases like TB, 
listeriosis, salmonellosis and legionellosis (Serbina et al., 2008; Tam et al., 2008; Torrado et 
al., 2007). During such close interaction, neutrophils have been shown to be able to increase 
the antimicrobial action of macrophages by providing potent antimicrobial molecules for 
which macrophages are deficient (Miyakawa et al., 1996). In addition, apoptotic neutrophils 
have been shown to induce pro-inflammatory response in macrophages (Tan et al., 2006).  
 1.19 Objectives of the study 
Neutrophils have been implicated in the innate immune response during the initial phase of 
mycobacterial infection. However, the role of neutrophils in mycobacterial infection is not 
fully understood. While the mechanisms by which virulent mycobacteria are able to 
propagate inside macrophages by interfering with the phagosomal maturation process are 
known, whether virulent mycobacteria impact on defense mechanisms of neutrophils still 
remains largely unknown. Also, the effect of interaction between neutrophils and infected 
macrophages on intra-macrophage bacterial survival is not known. It has been reported that 
human clinical isolates, M. avium hominissuis SCH 228 and SCH 215 show differential in 
vitro virulence in human macrophages in terms of their generation time. However, such 
virulence-based behavior of these clinical isolates has not yet been studied in human 
neutrophils. Our group has previously shown that human neutrophils are able to phagocytize 
and kill the avian type strain Mycobacterium avium TMC 724 (M. avium) in vitro. Therefore, 
objective of this study was to investigate the differential cell-autonomous immune regulation 
of neutrophils upon infection with the two human clinical M. avium hominissuis isolates, 
SCH 228 and SCH 215. 
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2 Results 
2.1 Both clinical Mycobacterium avium isolates, SCH 228 and SCH 215, prevent 
killing by human neutrophils by inhibiting phago-lysosome fusion 
We have previously shown that human neutrophils phagocytize and kill the avian type strain, 
Mycobacterium avium TMC 724 in vitro (Hartmann et al., 2001). Here, we assessed the 
ability of human neutrophils to kill clinical isolates of M. avium hominissuis (SCH 228 and 
SCH 215) that were isolated from human patients. SCH 228 isolated from bone marrow of 
an AIDS patient and SCH 215 derived from the cervical lymph node of a 5 year old boy 
suffering from lymphadenitis colli exhibit differential growth rates in the HMDM model 
(Meyer et al., 1998). Freshly isolated neutrophils from healthy donors were allowed to 
phagocytize mycobacteria at a ratio of 1:1 (PMN/bacteria) for 15 min. Extracellular bacteria 
were then removed by differential sedimentation centrifugation. M. avium rescued from 
neutrophils at defined time points of the incubation period at 37°C,  were cultured for 7–14 
days and the colony forming units/1000 µl (CFUs/1000 µl) of M. avium were determined. 
Analysis of CFU showed that SCH 228 and SCH 215 had been phagocytized with similar 
efficiency at 15 min (Fig. 1). However, following phagocytosis CFUs did not decrease over 
time, indicating that human neutrophils could not kill these clinical M. avium isolates. 
 
  
Figure 1 M. avium strains SCH 228 and SCH 215 are not killed by human neutrophils.  	  
Neutrophils were infected with SCH 228 (A) or SCH 215 (B) at a ratio of 1:1 at 37°C and allowed to 
phagocytize for 15 min. After removal of extracellular bacteria, CFUs of intracellular bacteria were determined 
at the indicated time points (min). The graph shows the mean values of three independent experiments with 
duplicates at each time point in each experiment. Error bars indicate standard error of mean (SEM) (p  >0.05, 
ns). 
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Figure 2 SCH 228 and SCH 215 M. avium inhibit phago-lysosomal processing in human neutrophils.  	  
Human neutrophils were infected with C12-FDG-coated SCH 228 (A) or SCH 215 (B) or heat-inactivated 
mycobacteria (D) for 15 min at 37°C (ratio 1:20). Neutrophils fed with C12-FDG-coated magnetic beads (C) 
were used as positive control for this assay. After removal of extracellular mycobacteria, cells were incubated 
and fluorescence was analyzed by flow cytometry at the indicated time points (color scheme). Phagosomal 
processing is shown by the shift in the fluorescence over time. Processing of C12-FDG-coated heat-inactivated 
mycobacteria (HI) vs intact mycobacteria was analyzed after 2 h post-infection and represented as the mean 
fluorescence intensity (D). Results are representative of three independent experiments.  
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Virulent mycobacteria are known to reside within the phagosome of infected macrophages 
by inhibiting phago-lysosomal fusion thereby preventing their degradation (Rohde et al., 
2007a; Rohde et al., 2007b; Russell, 2001; Russell et al., 2010b; Sweet et al., 2010). We 
therefore, asked whether inhibition of phago-lysosomal fusion in SCH 228 and SCH 215-
infected human neutrophils could be responsible for the observed bacterial survival 
(CFU/ml).  For this purpose, we employed C12 FDG (5-Dodecanoylaminofluorescein Di-β-
D-Galactopyranoside), a substrate for β-galatosidase enzyme, present in the lysosome, to 
study phagosomal processing using FACS (Robinson et al., 2008). Mycobacteria coated with 
C12-FDG were used to infect neutrophils and chased for up to 5 h. Magnetic beads coated 
with C12- FDG served as a positive control in this assay. As shown in Fig. 2C, neutrophils 
fed with C12-FDG coated magnetic beads showed an increase in fluorescence over time 
suggesting that the galactopyranoside coating on magnetic beads is cleaved by lysosome 
resident β-galatosidase upon phago-lysosome fusion. On the contrary, neutrophils infected 
with C12-FDG coated SCH 228 or SCH 215 M. avium did not show such increase in 
fluorescence indicating that lysosomes did not fuse with the mycobacteria containing 
phagosomes (Fig. 2A and B). In order to test whether these isolates actively inhibit phago-
lysosomal fusion, we used heat-inactivated mycobacteria for this assay. Neutrophils infected 
with C12-FDG coated heat-inactivated mycobacteria showed increased fluorescence 
compared to live mycobacteria suggesting that heat inactivated mycobacteria are not able to 
inhibit phago-lysosomal fusion as compared to live mycobacteria (Fig. 2D). Together, these 
data show that SCH 228 and SCH 215 M. avium clinical isolates prevent killing in human 
neutrophils by actively inhibiting the fusion of lysosomes with the phagosome. 
 
2.2 M. avium  SCH 228 and SCH 215 dampen the activation of p38 MAPK in human 
neutrophils 
Clearance of pathogens by neutrophils upon phagocytosis requires efficient degranulation, 
production of reactive oxygen species (ROS) and phagosomal processing, which is aided by 
the induction of appropriate cytokines (Sabroe et al., 2005; Sabroe et al., 2003; Segal, 2005; 
Winterbourn and Kettle, 2013; Yoshimura and Takahashi, 2007). Activation of p38 MAPK 
in neutrophils is important for various functions including degranulation, increased ROS, 
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cytokine induction, etc. (Lee et al., 1994; Mocsai et al., 2000; Peroval et al., 2013; Thomas 
and Schroder, 2013; Zu et al., 1996; Zu et al., 1998). Therefore, we analyzed whether these 
clinical isolates have any influence on the activation of p38 MAPK pathway, by western 
blotting. The activation of p38 MAPK in infected neutrophils is reduced in the early time 
points from 15 min till 60 min (Fig. 3). Notably, this reduction in the activation of the 
pathway is stronger in SCH 228 infected neutrophils than in SCH 215-infected cells.  Thus 
both SCH 228 and SCH 215 M. avium clinical isolates differentially dampen the activation 
of p38 MAPK signaling pathway. 
 
 
Figure 3 SCH 228 and SCH 215 dampen the phosphorylation and activation of p38 MAPK in human 
neutrophils.  	  
Mycobacteria-infected human neutrophils were lysed at the indicated time points and phosphorylation of p38 
MAPK was assessed by immuno-blotting using anti-phospho p38 MAPK antibody as described in Materials 
and Methods.  
 
2.3 SCH 228 and SCH 215 M. avium dampen p38 MAPK mediated degranulation in 
human neutrophils 
Killing of intracellular pathogens by neutrophils involves both oxidative and non-oxidative 
mechanisms. Degranulation, the non-oxidative mechanism is an important feature of 
neutrophils in the defense of both extra- and intracellular pathogens and is mediated by p38 
MAPK activation (Borregaard, 2010; Borregaard et al., 2007; Faurschou and Borregaard, 
2003; Prince et al., 2011; Segal, 2005; Thomas and Schroder, 2013; Winterbourn and Kettle, 
2013). Expression and fusion of contents from various granules with phagosomes result in 
intra-phagosomal degradation of pathogens. Therefore, we investigated whether the 
observed interference of SCH 228 and SCH 215 M. avium with the phosphorylation and 
activation of p38 MAPK impacts on the degranulation process. For this purpose, human 
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neutrophils were infected with either SCH 228 or SCH 215 and cell surface expression of 
CD35, CD63, and CD66b was measured for assessing degranulation of secretory, 
azurophilic, and specific granules, respectively, by flow cytometry.  The N-formylated 
peptide, fMLP, was used as a positive control for the p38 MAPK-mediated degranulation. 
Fig. 4 shows the cell surface expression of granule specific markers in human neutrophils at 
15 min. fMLP induced cell surface expression of both CD66b and 35 (Fig. 4B and C; blue 
bar) but not CD63 (Fig. 4A, blue bar). In striking contrast, both isolates dampened the 
expression of CD66b and 35 markers in infected human neutrophils by ≈66 and 50%, 
respectively.  
This inhibition in degranulation in M. avium-infected neutrophils was similar to the 
degranulation pattern in cells pre-incubated with p38 MAPK inhibitor (SB203580) for 30 
min (brown bar) before being stimulated with fMLP indicating the role of p38 MAPK in 
degranulation. These data show that both SCH 228 and SCH 215 dampen p38 MAPK 
mediated degranulation in human neutrophils.  
 
 
Figure 4 SCH 228 and SCH 215 M. avium dampen p38 MAPK mediated degranulation in neutrophils.  	  
Neutrophils were infected with mycobacteria SCH 228 (red) or SCH 215 (green) at a ratio of 1:10 for 15min 
and infected cells were analyzed for the cell surface expression of granule specific markers CD63 (A), CD35 
(B) and CD66b (C) for assessing degranulation of azurophilic, secretory and specific granules, respectively, by 
flow cytometry. Neutrophils were incubated in the presence of HBSS buffer (control; grey), fMLP (10 µM) for 
15 min (blue) or p38 MAPK inhibitor (2 µM) for 30 min prior to stimulation with fMLP for 15 min (brown). 
Data represent mean ± SEM of three independent experiments (*p <0.05). 
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2.4 SCH 228 and SCH 215 M. avium induce ROS differentially in human neutrophils 
Production and release of reactive oxygen species (ROS) is a crucial antibacterial 
mechanism of neutrophils, also mediated by p38 MAPK (Brumell et al., 1996; Makni-
Maalej et al., 2013; Segal, 2005; Sue et al., 1997; Thomas and Schroder, 2013). ROS when 
released into the phagosome could by itself kill intra-phagosomal pathogens (Segal, 2005; 
Winterbourn and Kettle, 2013). As shown above SCH 228 reduced the activation of p38 
MAPK pathway stronger than SCH 215 (Fig. 3). Using a luminol-based assay, we measured 
the ROS induction in neutrophils infected with either SCH 228 or SCH 215 for a period of 4 
h (Fig. 5). ROS produced by uninfected neutrophils was considered as the baseline and 
fMLP was used as positive control for this assay. The kinetics of the ROS production 
revealed that fMLP induced ROS, reached its peak at 15 min and fell to baseline at 30 min 
(Fig. 5A, blue line). Surprisingly, SCH 215 induced a robust production of ROS after 15 min 
and reached its peak between 90-120 min (Fig. 5A, green line). The total amount of the 
accumulated ROS started to fall thereafter. In contrast, SCH 228 induced significantly lower 
levels of ROS in neutrophils but with similar kinetics as that of SCH 215 (Fig. 5A, red line). 
Notably, even after reaching their respective peaks, the levels of ROS did not return to basal 
levels. Instead, both isolates induced ROS in moderate amounts in neutrophils through out 
the entire period of the kinetics.  
In order to prove the inhibitory effect of SCH 228 we measured the ROS induction in 
neutrophils infected with SCH 215 alone or in the presence of SCH 228. As expected, ROS 
induced in neutrophils co-infected with both SCH 215 and SCH 228 isolates was 
significantly reduced when compared to the ROS induced by SCH 215 alone (Fig. 5C, 
compare green and orange lines). These data indicate that SCH 228 inhibits ROS induction 
in the neutrophils. The ROS induced by these isolates decreased significantly in neutrophils 
that had been pre-treated with SB203580 (p38 MAPK inhibitor) suggesting that indeed p38 
MAPK mediates ROS induction in infected neutrophils (Fig. 5B). Together these data 
demonstrate that these isolates differentially impede ROS induction in neutrophils by 
reducing the activation of p38 MAPK and SCH 228 is capable of inhibiting ROS induction 
by SCH 215.  
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Figure 5 ROS induction in mycobacteria-infected human neutrophils.  	  
A. Kinetics of the ROS induction in human neutrophils measured over a period of 4 h. Human neutrophils were 
incubated with TC medium, SCH 228 (red), SCH 215 (green) or fMLP (blue) (10 µM) and total ROS was 
measured using luminol-based assay. Result is representative of three independent experiments. B. p38 MAPK 
mediates the induction of ROS in mycobacteria-infected neutrophils. Neutrophils were pre-incubated with p38 
MAPK inhibitor for 30 min before mycobacteria or fMLP was added. Data represent mean±SEM of the peak 
value for each sample from three different donors. C. SCH 228 inhibits ROS induced by SCH 215. Neutrophils 
were incubated with SCH 215 (Ratio 1:100) alone or with 228 (Ratio 1:50). Data represent mean±SEM of the 
peak value for each sample from three different donors (**p <0.005, ***p <0.0005). 
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2.5 SCH 228 and SCH 215 M. avium induce only certain cytokines differentially in 
infected neutrophils 
Neutrophils release cytokines not only to support and maintain their own functions but also 
to communicate and influence the function of other immune cells (Jaillon et al., 2013; 
Makni-Maalej et al., 2013; Mantovani et al., 2011; Nathan, 2006; Silva, 2010b; Zu et al., 
1996; Zu et al., 1998). Neutrophils have been shown to produce pro inflammatory cytokines 
such as IL-6, IL-8, IL-1β, TNF-α, and anti-inflammatory cytokines such as IL-1RA and IL-
10, and induction of these cytokines is mediated by p38 MAPK (Chi et al., 2006; Herlaar 
and Brown, 1999; Lee et al., 1994; Mayer et al., 2013). Therefore, we investigated whether 
reduced activation of p38 MAPK pathways upon infection impacts on the cytokine release 
from human neutrophils. To this end, neutrophils were incubated with SCH 228 or SCH 215 
and the concentration of various cytokines was measured in the supernatants after 6 h, using 
commercially available ELISA kits. Most of the cytokines including IL-6, IL-1β, TNF-α and 
IL-10 were not induced in the infected neutrophils as indicated by their concentration below 
the detection levels (data not shown). IL-1ra, the receptor antagonist of IL-1 was lower in the 
supernatant of neutrophils infected with SCH 228 than either SCH 215 infected or 
uninfected cells (Fig. 6B). On the other hand, infected neutrophils induced IL-8 production 
higher than uninfected neutrophils (Fig. 6A). SCH 215-infected neutrophils induced 8-fold 
increase in IL-8 production while SCH 228 induced about 3-fold (Fig. 6A, compare green 
and red lines). These cytokine data reveal that both isolates dampen cytokine production in 
neutrophils and differentially induce IL-8 production in human neutrophils.
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Figure 6 IL-8 and IL-1ra are differentially induced by SCH 228 and SCH 215 in infected neutrophils.  	  
Neutrophils were incubated with SCH 228 (red) or SCH 215 (green) (ratio 1:50) and supernatants were 
collected at indicated time points (hours). Levels of various cytokines and chemokines were measured using 
commercially available kits as per manufacturer’s instructions. A. Kinetics of IL-8 induction in infected 
neutrophils. B. IL-1ra levels in neutrophils after 6 h of incubation. Data represent mean±SEM from three 
different donors.  
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Figure 7 IL-8 induction in infected neutrophils is mediated by p38 MAPK via ROS. 	  
Neutrophils pre-treated with p38 MAPK inhibitor (2 µM) (A) or fMLP (10 µM) (D) for 30 min or untreated 
neutrophils were incubated with mycobacteria alone or in presence of ROS (H2O2; 400 nM) (C) or SOD (50 
µg/mL) (B). Supernatants were collected after 6 h and concentration of IL-8 was measured. Data represent 
mean±SEM from three different donors. 
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2.6 IL-8 induction in M. avium infected human neutrophils is p38 MAPK and ROS 
dependent 
The kinetics of ROS production and IL-8 release show that ROS production happens earlier 
than IL-8 release. This observation leads to the hypothesis that P38 MAPK and ROS are 
important for the induction of IL-8. To test this hypothesis, first, we checked whether release 
of IL-8 is ROS- dependent. Inhibition of ROS using super oxide dismutase (SOD) a ROS-
scavenger significantly reduced the levels of IL-8 (Fig. 7B). Moreover, exogenous addition 
of hydrogen peroxide (H2O2, ROS metabolite) to neutrophils enhanced IL-8 induction in 
neutrophils  (Fig. 7C). These data confirm that the IL-8 induction in M. avium-infected 
human neutrophils is ROS-dependent. Next, we checked the involvement of p38 MAPK in 
IL-8 induction using p38 MAPK inhibitor and activator (fMLP). IL-8 induction in 
mycobacteria infected neutrophils that were pre-treated with SB203580 and fMLP was 
significantly reduced and induced, respectively (Fig. 7A and D). These data together indicate 
that the production of IL-8 in the infected neutrophils is mediated by p38 MAPK via ROS. 
 
2.7 IL-8 induces degranulation in neutrophils  
From our results, it is evident that the two clinical isolates of M. avium hominissuis prevent 
killing in neutrophils by dampening the activation of the p38 MAPK, a pathway involved in 
many neutrophil functions. As various processes of neutrophils cross talk and influence one 
another, it is tempting to find out whether the function of neutrophils such as ROS 
production, cytokine induction and degranulation are interlinked to one another. Our data 
showed that the IL-8 production is mediated by p38 MAPK and ROS. It is known that IL-8 
primes neutrophils for ROS production. However, whether or not IL-8 has any influence on 
degranulation was not studied in neutrophils. To study this, neutrophils were stimulated with 
IL-8 for 15 min, and degranulation was assessed as mentioned above. Stimulation with IL-8 
induced degranulation of all the vesicles in treated neutrophils compared to untreated 
neutrophils (Fig. 8). This result shows that IL-8 induction via ROS upon p38 MAPK 
activation induces the degranulation process. 
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Figure 8 IL-8 induces degranulation in neutrophils.  	  
Neutrophils were incubated with HBSS buffer (grey) or IL-8 (pink; 50 pg/mL) for 15 min and cells were 
analyzed for the cell surface expression of granule specific markers CD63 (A), CD35 (B) and CD66b (C) for 
assessing degranulation of azurophilic, secretory and specific granules, respectively, by flow cytometry. 
Results are representative of three independent experiments. 
 
2.8 ROS and IL-8 do not affect the killing of SCH 228 by human neutrophils  
SCH 228 dampens the activation of p38 MAPK pathway and thus, reduces ROS and IL-8 
induction in neutrophils. IL-8 is a strong neutrophil priming agent. Given the fact that ROS 
mediated IL-8 induction and degranulation are interlinked (Fig. 7 and 8), we hypothesized 
that the addition of IL-8 or exogenous ROS could enhance bacterial clearance in infected 
neutrophils. To test this hypothesis, neutrophils pre-treated with IL-8 for 15 min or ROS for 
30 min were infected with SCH 228 for 15 min and the CFU was compared to that of 
untreated SCH 228 infected cells. Neither IL-8 nor ROS treatment showed any effect on 
bacterial clearance (data not shown). These results suggest that exogenous addition of IL-8 
or ROS does not enhance the killing of SCH 228 by neutrophils. 
 
2.9 Stimulation by LPS does not affect killing of SCH 228 or SCH 215 by human 
neutrophils  
Priming processes are critical in host defense against intracellular pathogens (Wright et al., 
2010). Lipopolysaccharide (LPS) is also known as a strong priming agent that enhances 
many functions of neutrophils via TLR4 (Brinkmann et al., 2004). Hence, we asked if LPS -
14613%
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stimulated neutrophils would exhibit a better clearance of bacteria than unstimulated ones. 
Neutrophils were stimulated with LPS for 30 min before they were infected with SCH 228 
and SCH 215 and the number of bacteria present in the neutrophils was determined at 
selected time points. In contrast to our expectation, LPS-stimulated neutrophils did not show 
decreased CFUs compared to unstimulated neutrophils (Fig. 9). Thus, we conclude that both 
isolates SCH 215 and SCH 228, prevent killing by LPS-stimulated neutrophils. 
 
Figure 9 Priming with LPS does not enhance SCH 228 and SCH 215 killing by human neutrophils.  	  
M. avium SCH 228 (A) and SCH 215 (B) were incubated with LPS stimulated neutrophils (filled bars) and 
unstimulated neutrophils (open bars) for indicated time points. Bacterial survival was determined by CFU 
counts of cell lysates. Data represent mean±SEM from three different donors. (p >0.05, ns). 
 
2.10 M. avium isolates, SCH 228 and SCH 215, do not alter neutrophil death pathways  
Microbial pathogens are capable of modulating host cell death as a virulence mechanism. 
Infected host cells are induced to undergo either apoptosis or necrosis through activation of 
various pathways including oxygen-dependent mechanisms (Abebe et al., 2011; Chen et al., 
2006; Luo, 2011; Perskvist et al., 2000). Since, we have observed differential induction of 
ROS by these isolates in human neutrophils, we checked whether these clinical M. avium 
strains, SCH 228 and SCH 215 have any influence on the death of infected neutrophils. 
Using a commercially available Annexin V-apoptosis assay kit, we measured Annexin V 
positive and 7-AAD-postive cells among neutrophils that were infected with either SCH 228 
or SCH 215 for 0 and 3 h. Uninfected neutrophils were considered as negative control while 
neutrophils incubated with phorbol myristate acetate (PMA) for 30 min were used as 
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positive control for this assay. Neutrophils stained positive for Annexin V alone represent 
apoptotic cells while cells positive for both Annexin V and 7-AAD were considered as late 
apoptotic or necrotic cells. At both time points, apoptosis of neutrophils infected with SCH 
228 or SCH 215 was not significantly different than spontaneous apoptosis in uninfected 
neutrophils (Fig. 10A). On the other hand, PMA induced significant apoptotic cell death 
compared to uninfected neutrophils. Similarly, Annexin V+ and 7-AAD+ necrotic cell death 
of neutrophils incubated with these isolates was not different than uninfected neutrophils 
(Fig. 10B). These data suggest that virulence of SCH 228 or SCH 215 M. avium clinical 
isolates does not induce cell death in human neutrophils.  
 
 
Figure 10 M. avium isolates, SCH 228 and SCH 215, do not alter neutrophil death pathways. 	  
Neutrophils were infected with mycobacteria SCH 228 (red) or SCH 215 (green) at a ratio 1:10 at 37 °C for up 
to 3 h. At indicated times, cells were collected and dead cells were measured using commercially available 
Annexin V apoptosis kit, by flow cytometry. Uninfected neutrophils served as the negative control (grey) while 
cells incubated with PMA were considered as a positive control (brown). Cells stained positive for Annexin V 
represent apoptotic cells (A) while cells positive for both Annexin V and 7-AAD were considered as the late 
apoptotic/necrotic cells (B). Cell death measured after 15 min of phagocytosis was considered as 0 h. after Data 
represent mean±SEM from three different donors (p >0.05, ns). 
 
2.11 Cytochalasin B/fMLP stimulated degranulation inhibits extracellular growth of 
SCH 228 and SCH 215 M. avium 
Neutrophils discharge their storage granules both into phagosomes and to the extra cellular 
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2005; Thomas and Schroder, 2013). Neutrophils can be artificially induced to degranulate 
their granular contents into the supernatant. A combination of cytochalsin B (cytB), a fungal 
metabolite and fMLP has been shown to release contents from azurophilic and 
specific/gelatinase granules(Bentwood and Henson, 1980; Zarember et al., 2007). Soluble 
factors from the granules released outside the cell contribute to the extracellular killing of 
pathogens (Borregaard, 2010; Borregaard et al., 2007). Therefore, we asked whether 
stimulated degranulation from neutrophils could have an inhibitory effect on extracellular 
mycobacterial growth. First, cytB/fMLP induced degranulation after 30 min was assessed by 
the cell surface expression of granule specific markers by flow cytometry. As expected, 
incubation of neutrophils with cytB/fMLP resulted in increased expression of CD66b and 
CD63 compared to the solvent stimulated or unstimulated neutrophils (Fig. 11A and C). 
However, expression of CD35 in stimulated neutrophils was not increased (Fig. 11B). These 
data clearly demonstrate that cytB/fMLP stimulation in neutrophils induces degranulation of 
both azurophilic and specific/gelatinase granules. Having confirmed the degranulation from 
stimulated neutrophils, next, we asked if cytB/fMLP stimulated supernatant could inhibit 
extracellular growth of these isolates. Following cytB/fMLP stimulation, neutrophils were 
pelleted and 100 µl of supernatant from the equivalent of 107 neutrophils were added to 105 
CFU of SCH 228 and SCH 215. The survival of these strains was determined by counting 
the bacteria in the supernatant after 24 and 48 h. Interestingly, CFU of both SCH 228 and 
SCH 215 was significantly decreased when incubated with supernatant from cytB/fMLP-
stimulated neutrophils than that of solvent-stimulated or unstimulated neutrophils at 48 h 
(Fig. 11D and E). This result indicates that cytB/fMLP induced degranulation of neutrophils 
inhibits extracellular growth of these two clinical M. avium isolates.  
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Figure 11 Granular components of human neutrophils inhibit extra-cellular growth.  	  
Neutrophils were incubated with solvents or stimulants, CytB/fMLP for 30 min at 37°C and cells were 
analyzed for the cell surface expression of granule specific markers CD63 (A), CD35 (B) and CD66b (C) for 
assessing degranulation of azurophilic, secretory and specific granules, respectively, by flow cytometry. Cells 
incubated in the TC medium were considered as control. An aliquot (100 µL) of the supernatants from the 107 
degranulated neutrophils were incubated with 105 SCH 228 (D) or SCH 215 (E) at 24 and 48 h. The effect of 
supernatants on survival of mycobacteria is shown. Data represent mean±SEM from three different donors. (*p 
<0.05). 
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2.12 Supernatant from SCH 228 or SCH 215-infected neutrophils inhibits 
extracellular growth of Staphylococcus aureus but not M. avium 
Our degranulation study indicates that both SCH 228 and SCH 215 interfere with the 
degranulation in infected neutrophils. To investigate whether supernatant from SCH 228 or 
SCH 215 infected neutrophils support extracellular growth of M. avium, SCH 228 and SCH 
215 were incubated with the supernatant from SCH 228 or SCH 215 infected neutrophils and 
the survival (CFUs) of these two clinical isolates in the supernatant was determined after 48 
h. Supernatant from unstimulated neutrophils was used as control. Although supernatant 
from cytB/fMLP degranulated neutrophils did affect the viability of both the isolates 
compared to control supernatant, supernatants from neutrophils infected either with SCH 
228 or SCH 215 did not decrease SCH 228 and SCH 215 mycobacterial survival (Fig. 12A 
and B). These results show that the supernatant from SCH 228 or SCH 215 infected 
neutrophils does not inhibit the extracellular growth of SCH 228 and SCH 215, and suggest 
that the supernatant from mycobacteria-infected neutrophils differ in their contents from that 
of cytB/fMLP induced neutrophils in terms of degranulation. 
In order to prove that the contents of the degranulated supernatant from infected neutrophils 
are different from cytB/fMLP induced supernatant, survival of S. aureus (SA), an 
extracellular pathogen was tested. SA was incubated with the supernatant from cytB/fMLP 
stimulated, SCH 228, SCH 215 or SA-infected or uninfected neutrophils and its survival in 
these supernatants was determined after 2 and 4 h by CFU counts (Fig. 12). Supernatant 
from neutrophils infected with SA did not affect their own survival. Also, supernatant from 
cytB/fMLP stimulated neutrophils, which had earlier shown to affect mycobacterial 
extracellular growth, did not affect SA growth in the supernatant (Fig. 12C and D). 
However, importantly, supernatant from mycobacteria-infected neutrophils significantly 
prevented SA extracellular growth. Interestingly, supernatant from SCH 215-infected 
neutrophils prevented SA growth significantly more than SCH 228. These data together 
demonstrate that supernatants from SCH 228 and SCH 215- infected neutrophils prevent SA 
extracellular growth and contents as well as antibacterial effects of the degranulated 
supernatant from neutrophils vary depending upon the stimuli or pathogen.  
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Figure 12 Neutrophil degranulation induced by mycobacteria does not impact on their extra cellular 
growth but significantly inhibits extra cellular growth of SA. 	  
Neutrophils were incubated with TC medium, SCH 228, SCH 215, SA or CytB/fMLP for 30 min at 37°C. An 
aliquot (100 µL) of the supernatants from the 107 degranulated neutrophils were incubated with 105 SCH 228 
(A) or SCH 215 (B) for 24 and 48 h. In other experiments, supernatants were incubated with 104 SA for 2  (C) 
and 4 h (D). The effect of supernatants on survival of mycobacteria or SA is shown. Data represent 
mean±SEM from three different donors. (*p <0.05, **p <0.005, ***p <0.0005). 
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2.13 LPS-stimulated or unstimulated neutrophils do not affect survival of SCH 228 
and SCH 215 in human macrophages in contact co-culture experiments 
Neutrophils are persistently recruited to the site of infection and are present in the 
granulomas in humans (Eum et al., 2010; Martineau et al., 2007). Although neutrophils are 
terminally differentiated, when stimulated with pathogens or cytokines they can produce cell 
mediators such as cytokines and chemokines. These cell mediators are known to interact 
with and have paracrine effects on infected macrophages and aid in the defense against 
mycobacterial infection. Even though, many studies have suggested that neutrophils 
contribute to the early defense against mycobacteria, contradictory studies exist (Lowe et al., 
2012).  Therefore, to evaluate the relevance of the interactions between neutrophils and 
macrophages in host defense against mycobacterial infection, survival of M. avium 
hominissuis in macrophages was analyzed in co-culture experiments. First, we checked the 
effect of naïve neutrophils on mycobacterial survival in infected macrophages. Freshly 
isolated naïve neutrophils were co-cultured with the SCH 228 or SCH 215-infected 
macrophages and the number of viable bacteria present in the macrophages was determined 
after 48 and 72 h. At 48 and 72 h, the levels of viable intracellular mycobacteria in 
macrophages did not differ with or without addition of neutrophils (Fig. 13).  
Previous studies have shown that LPS stimulation augments the antimicrobial activity of 
neutrophils. Therefore, we tested if LPS stimulated neutrophils enhance clearance of 
intracellular bacteria in the infected macrophages. To this end, we compared the bacterial 
burden in the infected macrophages cultured in the presence or absence of LPS-stimulated 
neutrophils. No significant difference in the bacterial burden was observed between the co-
culture of unstimulated and LPS-stimulated neutrophils (Fig. 13). 
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Figure 13 Bacterial survival of SCH 228 and SCH 215 do not differ in human macrophages co-cultured 
with LPS-stimulated or unstimulated neutrophils. 	  
Mycobacteria-infected human macrophages were incubated with LPS stimulated neutrophils or unstimulated 
neutrophils at a ratio of 1:1 for 48 and 72 h. At indicated time points bacterial survival of M. avium SCH 228 
(A) and SCH 215 (B) was determined by CFUs from cell lysates. Mycobacterial survival in macrophages 
without neutrophils was considered as control. Data represent mean±SEM from three different donors. (p 
>0.05, ns). 
 
2.14 SCH 228 and SCH 215-induced degranulation does not affect intracellular 
survival of these isolates in human macrophages in non contact co-culture 
experiments 
We have shown that SCH 228 and SCH 215 inhibit degranulation in human neutrophils. 
Moreover, the contents in the supernatant from SCH 228 infected neutrophils differ from 
SCH 215. Also, we have demonstrated that these contents have the ability to inhibit 
extracellular growth of S. aureus. Hence, we asked whether these contents could affect the 
intracellular growth of mycobacteria in macrophages. Infected macrophages were grown in 
the presence of supernatant from uninfected or infected neutrophils and bacterial burden was 
determined after 48 and 72 h (Fig. 14). Analysis of this non cell-contact co-culture 
experiment revealed that both supernatants did not affect the intracellular bacterial burden of 
SCH 228 and SCH 215 in the infected macrophages.  
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Figure 14 Mycobacteria-induced degranulation does not affect intracellular survival of SCH 228 and 
SCH 215 in human macrophages. 	  
Mycobacteria-infected human macrophages were incubated with degranulated supernatants for 48 and 72 h. At 
indicated times, bacterial survival of M. avium SCH 228 (A) and SCH 215 (B) was determined as CFUs from 
cell lysates. Mycobacterial survival in macrophages incubated with supernatant from unstimulated neutrophils 
was considered as control. Data represent mean±SEM from three different donors. (p >0.05, ns). 
 
2.15 M. avium infected macrophages induce exocytosis of CD66 vesicles predominantly 
in naïve neutrophils in a time dependent manner 
Secretion of anti-microbial peptides and cell mediators from neutrophils is mediated by 
degranulation, which is inhibited in SCH 228 and SCH 215 infected neutrophils. However, 
whether infected macrophages could induce degranulation in naïve neutrophils is not known. 
Thus, we investigated the degranulation of naïve neutrophils upon co-culturing with infected 
macrophages. Freshly isolated naïve neutrophils were allowed to interact with previously 
infected macrophages for 30, 60 and 120 min before they were harvested and analyzed for 
the cell surface expression of the granule specific markers by flow cytometry. The 
degranulation induced upon the interaction with uninfected naïve macrophages was 
considered as control. Infected macrophages induced cell surface expression of only CD66b 
but not CD63 or CD35 in naïve neutrophils upon interaction compared to uninfected 
macrophages (data not shown). This up-regulation in CD66b expression increased in 
neutrophils from 30 to 120 min upon interacting with SCH 215-infected macrophages. Such 
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an increase in CD66b expression in neutrophils that interacted with 228-infected 
macrophages was observed from 30 to 60 min, but not at 120 min (Fig. 15). These data show 
that SCH 215 and SCH 228-infected macrophages predominantly induce specific/gelatinase 
granules release in naïve neutrophils. These data also importantly show that SCH 228-
infected macrophages induced CD66b expression in neutrophils only for a shorter time, 
again highlighting the differential induction of granules by these two clinical isolates. 
 
Figure 15 SCH 228 or SCH 215-infected macrophages induce predominantly specific/gelatinase 
degranulation in naïve neutrophils in a time dependent manner.  	  
Mycobacteria-infected human macrophages were incubated with freshly isolated naïve neutrophils. At 
indicated time points neutrophils were harvested and analyzed for the cell surface expression of the granule 
specific marker CD66b for assessing degranulation of specific granules, by flow cytometry. Neutrophils 
incubated with uninfected macrophages were considered as control (grey line). Red line and green line indicate 
CD66b on neutrophils co-incubated with SCH 228 and SCH 215 infected macrophages respectively. Data 
represent mean±SEM from three different donors. (* p <0.05). 
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attractants for neutrophils and monocyte/macrophages. We analyzed supernatants from M. 
avium infected monocytes (THP-1 cells) for their ability to attract neutrophils in a Boyden 
chamber plate migration assay. Reciprocal experiments were performed using supernatants 
from infected neutrophils to attract THP-1/monocyte derived macrophages (MDM) and vice 
versa. The results show that supernatants from infected THP-1/MDM exhibit chemo-
attractivity towards human neutrophils, but not vice versa (Hartmann, 2006) Interestingly, 
both intact and heat killed M. avium attracted neutrophils. None of the cytokines and 
chemokines present in the supernatant were alone responsible for the observed chemo-
attractivity (Hartmann, 2006). This shows that other factor(s) present in the supernatant 
probably also in combination of cytokines and chemokines are responsible for the observed 
chemoattraction. Mass spectrometric  (mass spec) analysis of the fraction, which retained the 
activity, consistently revealed the presence of heat shock protein 70 (HSP70). Since, HSP70 
is an exosomal marker, we analyzed whether exosomes have the ability to attract 
neutrophils. THP macrophages were incubated with TC medium or M. avium SCH 228 or 
SCH 215 for 4 h at 37°C. After incubation, extracellular mycobacteria were removed and 
cells were incubated for 72 h. Exosomes were then isolated from the supernatants of 
uninfected or infected THP macrophages using differential centrifugations (Fig. 16A) to 
remove cells and cell debris. Further purification steps were performed on non-linear sucrose 
gradient by ultracentrifugation to remove non-membranous proteins, protein aggregates and 
other larger vesicles. Exosomes were confirmed by presence of exosomal markers Hsp70, 
Rab5 and 7, and MHC 1 and 2 (Fig. 16C). In addition, the preparations were examined and 
characterized for the size distribution of exosomes by transmission electron microscopy and 
were shown to be mostly 20–300 nm in diameter (Fig. 16E). 
Purified exosomes from uninfected and infected THP macrophages were used as the 
chemoattractants and checked for their ability to attract Calcein AM-loaded human 
neutrophils in a Boyden chamber plate migration assay. The migration of neutrophils 
towards chemoattractants was analyzed by fluorescence measured from the plate and filter of 
the Boyden chamber. As expected, neutrophils migrated towards Zymosan-activated serum 
(ZAS), the positive control for this assay. As expected from previous observations, 
exosomes from infected as well as uninfected macrophages attracted neutrophils. 
Interestingly, however, the exosomes released from M. avium-infected macrophages 
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attracted substantially higher number of neutrophils than those from uninfected macrophages 
(Fig. 17). Furthermore, to compare the protein profile of infected vs uninfected THP 
macrophage derived exosomes, total exosomal proteins were subjected to trypsin digestion, 
the extracted peptides were purified by strong cationic exchange column chromatography 
after iTRAQ labeling and the purified peptides were analyzed by nano-LC–MS/MS (Fig. 
16B). Protein database searching of MS/MS data resulted in identifying 648 proteins in THP 
macrophage derived exosomes. Mass spec analysis of the proteins present in the exosomes 
revealed the presence of also other exosomal markers apart from the aforementioned ones 
(Fig. 16D). The identified exosomal protein gene symbols were compared with the Exocarta 
database of exosomal proteins.  22 proteins from our preparation matched with the top 25 
proteins that were often identified in exosomal studies as exosomal markers (Fig. 16F). The 
high overlap of exosomal marker proteins between exosomes from THP macrophages and 
the Exocarta database suggests that our procedures used for exosomes isolation are 
reproducible and reliable. 
The identified proteins were annotated and classified according to subcellular localization, 
biological processes and molecular activity. Fig. 18 shows the subcellular localization of the 
identified proteins based on gene ontology using MASCOT analysis. Our exosome proteome 
contained proteins that are found to be located in the cytoplasm, intracellular organelles, 
membranes, cytoplasmic vesicles and other subcellular compartments. In terms of the 
biological processes as shown in Fig. 18B, among several functions the exosomal proteins 
are mainly involved in cellular, metabolic and biological processes, response to stimuli, cell 
communication. The molecular functions of these proteins are shown in Fig. 18C. THP 
macrophage-derived exosomes are enriched in proteins that have binding, enzyme regulatory 
and catalytic activities. Apart from host derived proteins, the mass spec analysis of these 
exosomes also revealed proteins from SCH 228 and SCH 215 M. avium (Table 1).  
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Figure 16 Isolation and characterization of exosomes derived from M. avium-infected THP macrophages. 	  
THP macrophages were incubated with TC medium (uninfected) or with M. avium (SCH 228 or SCH 215) for 
4 h at 37°C. After incubation, extracellular mycobacteria were washed and cells were incubated for 72 h. The 
culture supernatant was used to isolate exosomes. A. Strategy for the isolation and purification  of exosomes 
from culture supernatants  based on differential ultracentrifugation. B. Workflow for quantitative proteomics 
and summary of identification and quantification results. C. Immunoblot analysis of exosomal markers on 
exosomes prepared from uninfected or SCH 228 or SCH 215-infected  macrophages. D. Other exosomal 
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markers were detected in the mass spec analysis. E. Electron microscopy image of purified exosomes. F. Venn 
diagram showing the overlap in the number of proteins present in the exosomes from macrophages identified 
by mass spec and the number of exosomal markers listed in the Exocarta database.  
 
 
 
Figure 17 Exosomes released from M. avium infected macrophages induce neutrophil chemotaxis. 	  
THP macrophages were incubated with TC medium (uninfected) or with M. avium (SCH 228 or SCH 215) for 
4 h at 37°C. After incubation, extracellular mycobacteria were washed and cells were incubated for 72 h. 
Exosomes were isolated from the respective supernatants using sucrose density gradient centrifugation. Isolated 
exosomes (50 µg/ml) were checked for their ability to attract human neutrophils using Boyden chamber plate 
migration assay, as mentioned in the materials and method. 
 
 
 
 
 
Ex
o U
I
Ex
o S
CH
22
8
Ex
o S
CH
21
5
ZA
S
0
1000
2000
3000
R
el
at
iv
e 
flu
or
es
ce
nt
 u
ni
ts
 (N
or
m
al
iz
ed
)
	   52	  
 
 
 
0" 50" 100" 150" 200" 250" 300" 350" 400" 450" 500"
"Cell"surface"
"Chromosome"
"Cytoplasm"
"Cytoplasmic"vesicle"
"Cytoskeleton"
"Cytosol"
"Endoplasmic"re=culum"
"Extracellular"region"
"Golgi"apparatus"
"Intracellular"
"Intracellular"organelle"
"Membrane"
"Mitochondrion"
"Nucleus"
"Organelle"membrane"
"Organelle"part"
"Plasma"membrane"
"Protein"complex"
"Ribosome"
"Vacuole"
"Binding"
A 
0" 50" 100" 150" 200" 250" 300" 350" 400" 450" 500"
"Biological"regula2on"
"Cell"communica2on"
"Cell"death"
"Cell"growth"
"Cell"prolifera2on"
"Cellular"process"
"Coagula2on"
"Defense"response"
"Developmental"process"
"Establishment"of"localiza2on"
"Localiza2on"
"Metabolic"process"
"Mul2Dorganism"process"
"Mul2cellular"organismal"process"
"Regula2on"of"biological"process"
"Response"to"s2mulus"
"Sensory"percep2on"
"Transport"
B 
	   53	  
 
Figure 18 Classification of identified proteins present in the exosomes derived from THP-1 macrophages. 	  
Proteins present in the exosomes were identified by mass spec analysis. Classification of identified proteins by 
subcellular localization (A), processes (B) and activities (C) was done based on GO analysis using MASCOT. 
 
2.17 Prediction of putative neutrophil chemotactic factors on THP-macrophage 
derived exosomes 
Having shown the ability of exosomes in attracting neutrophils, we employed mass spec data 
to predict putative candidates for neutrophil chemotaxis. For this purpose, we performed 
detailed GO enrichment analysis of the proteins involved in cell communication. Out of the 
proteins involved in cell communication, we next sorted out proteins playing a role in cell 
migration and neutrophil chemotaxis. Table 2 shows the putative proteins on exosomes that 
participate in neutrophil chemotaxis. Proteins having a peptide score more than 40 and the 
amount of which was more than that present in exosomes released from uninfected THP 
macrophages were searched in GO, Exocarta, PUBMED and UniProt databases. 
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Interestingly, all of these candidate proteins were previously reported to be present on 
exosomes (Table. 2).  Analysis based on PUBMED search revealed that these proteins have 
been shown to be involved either directly or indirectly in migration of cells including 
neutrophils. Together, the presence of several potential putative chemoattractants on 
exosomes derived from M. avium-infected THP macrophages supports the result of our 
functional analysis that these exosomes are capable of attracting human neutrophils. 
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Table 1 List of mycobacterial proteins present in exosomes 	  
Accession Protein Mw (kDa) 
gi|516826014 
 
30S ribosomal protein S6 
[Corynebacterium 
mastitidis] 
11.3 
 
gi|492831729 
 
6-phosphofructokinase 
[Actinomyces graevenitzii] 
80.5 
 
gi|386739738 
 
adenylate kinase 
[Corynebacterium 
pseudotuberculosis 31] 
16.5 
 
gi|496916762 
 
ATPase/histidine 
kinase/DNA gyrase 
B/HSP90 domain protein 
[Actinomyces sp. oral 
taxon 181] 
30.8 
 
gi|118467500 
 
dimethylmenaquinone 
methyltransferase 
[Mycobacterium 
smegmatis str. MC2 155] 
22.6 
 
gi|491840837 
 
glyceraldehyde-3-
phosphate dehydrogenase 
[Mycobacterium 
hassiacum] 
35.3 
 
gi|495047224 
 
haloalkane dehalogenase 
[Mycobacterium 
colombiense] 
33.1 
 
gi|491285106 
 
hypothetical protein 
[Mycobacterium 
rhodesiae] 
66.6 
 
gi|489996938 
 
hypothetical protein, 
partial [Mycobacterium 
tuberculosis] 
17.2 
 
gi|433646793 
 
LOW QUALITY 
PROTEIN: adenylate 
kinase-like kinase 
[Mycobacterium 
smegmatis JS623] 
19.9 
 
gi|517431797 
 
membrane protein 
[Mycobacterium sp. 155] 
 
39.4 
 
gi|41410362 molecular chaperone 10.7 
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 GroES [Mycobacterium 
avium subsp. 
paratuberculosis K-10] 
 
gi|497429212 
 
phosphatase [Actinomyces 
sp. oral taxon 178] 
33.8 
 
 
 
 
Table 2 List of putative proteins on exosomes involved in neutrophil chemotaxis 	  
UniProt 
ID a 
Protein name a MW b 
(kDa)  
 
Location c Reported 
on 
Exosomes c  
Involved in 
cell 
migration 
 
ANXA4 Annexin A4 
(Endonexin-1) 
35.9 
 
-Extracellular 
vesicular 
exosomes 
-Cytoplasm 
(Buschow 
et al., 2010; 
Gonzales et 
al., 2009; 
Gonzalez-
Begne et al., 
2009) 
(Mogami et 
al., 2013) 
ITA5 Integrin alpha 5  
(CD49e- 
Fibronectin 
receptor subunit 
alpha) 
(VLA5-very late 
antigen 5) 
114.5 
 
-Membrane 
-Single-pass 
type1 
membrane 
-Cytoskeleton 
(Ji et al., 
2008) 
(Burns et 
al., 2001; 
van den 
Berg et al., 
2001) 
ITAX 
 
Integrin alpha X 
(CD11c) 
127.7 
 
-Membrane 
-Single-pass 
type1 
membrane 
-Cytoskeleton 
  
UPAR Urokinase 
plasminogen 
activator surface 
receptor  
(CD87-monocyte 
activation antigen 
Mo3) 
 
37.0 
 
-Membrane 
-Secreted 
(Jung et al., 
2009; Mu et 
al., 2013) 
(Dekkers et 
al., 2000; 
Gyetko et 
al., 1995; 
Liu et al., 
2011; 
Mukhina et 
al., 2000; 
Pliyev et al., 
2011) 
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ANXA1 Annexin A1 38.7 
 
-Membrane 
-Cytoplasm 
-Extracellular 
vesicular 
exosomes 
 
(Kesimer et 
al., 2009; 
Stamer et 
al., 2011) 
(Dalli et al., 
2012; 
Walther et 
al., 2000) 
SDCB1 Syntenin-1 32.4 
 
-Membrane 
-Cytoplasm 
-Cytoskeleton 
-Extracellular 
vesicular 
exosomes 
 
(Mears et 
al., 2004; 
Stamer et 
al., 2011) 
(Kim et al., 
2014; Sala-
Valdes et 
al., 2012) 
ITAV 
 
 
Integrin alpha V 
(CD51-Vitronectin 
receptor subunit 
alpha) 
116.0 
 
-Membrane 
-Single-pass 
type1 
membrane 
-Extracellular 
vesicular 
exosomes 
 
(Buschow 
et al., 2010; 
Gonzales et 
al., 2009) 
 
CD97 CD97 antigen 
(Leukocyte 
antigen) 
91.8 
 
-Membrane 
-Secreted 
-Extracellular 
vesicular 
exosomes 
 
(Buschow 
et al., 2010; 
Turiak et 
al., 2011) 
(Hamann et 
al., 2010; 
Leemans et 
al., 2004; 
Veninga et 
al., 2008; 
Wang et al., 
2007) 
CD44 CD44 antigen 81.5 
 
-Membrane 
-Cytoplasm 
-Extracellular 
vesicular 
exosomes 
 
(Buschow 
et al., 2010; 
Gonzalez-
Begne et al., 
2009) 
(Brazil et 
al., 2010; 
Khan et al., 
2004; Zech 
et al., 2012) 
BASI 
 
Basigin 
(CD147-leukocyte 
activation antigen 
M6) Extracellular 
matrix 
metalloproteinase 
inducer 
42.2 
 
-Extracellular 
vesicular 
exosomes 
-Membrane 
-Single-pass 
type1 
membrane 
(Buschow 
et al., 2010) 
(Damsker et 
al., 2009; 
Kato et al., 
2009; Lu et 
al., 2010) 
CD9 CD9 antigen 
(Leukocyte antigen 
MIC3) 
25.4 
 
-Extracellular 
vesicular 
exosomes 
-Membrane 
(Gonzales 
et al., 2009; 
Gonzalez-
Begne et al., 
(Powner et 
al., 2011) 
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-Single-pass 
type1 
membrane 
2009; 
Pisitkun et 
al., 2004) 
 
ADA10 
 
Disintegrin and 
metalloproteinase 
domain-containing 
protein 10  
(CD156c) 
84.1 
 
-Extracellular 
vesicular 
exosomes 
-Membrane 
-Single-pass 
type1 
membrane 
-Cytoplasm 
(Buschow 
et al., 2010; 
Padro et al., 
2013; 
Stoeck et 
al., 2006) 
(Blume et 
al., 2012; 
Schulz et 
al., 2008; 
Schwarz et 
al., 2010) 
CD45 Leukocyte 
common antigen 
147.2 
 
-Extracellular 
vesicular 
exosomes 
-Membrane 
-Single-pass 
type1 
membrane 
(Buschow 
et al., 2010; 
Wubbolts et 
al., 2003) 
(Harvath et 
al., 1991; 
Zhu et al., 
2011) 
LEG1 Galectin-1 
(Putative MAPK-
activating protein 
PM12) 
14.7 
 
-Cytoplasm 
-Secreted 
 
(Welton et 
al., 2010) 
(Auvynet et 
al., 2013) 
LEG3 Galectin-3 
(Mac-2 antigen) 
26.1 
 
-Extracellular 
vesicular 
exosomes 
-Cytoplasm 
-Secreted 
 
 
(Gonzales 
et al., 2009; 
Gonzalez-
Begne et al., 
2009; Thery 
et al., 2001; 
Welton et 
al., 2010) 
(Bhaumik et 
al., 2013; 
Sano et al., 
2000) 
LEG9 Galectin-9 39.5 
 
-Cytoplasm 
-Secreted 
 
(Keryer-
Bibens et 
al., 2006; 
Koumangoy
e et al., 
2011) 
 
 
a – based on Gene Ontology (GO) search; more than 40 peptide score; manually cured for 
their amount 
b – based on MASCOT analysis 
c – based on UniProt, GO, Exocarta and PUBMED search 
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3 Discussion 
Most of the investigations regarding the understanding of the pathophysiological behavior of 
M. avium are carried out using type strains or laboratory strains. However, naturally 
occurring M. avium infections are caused by strains that are widely different in genotype and 
phenotype. Very little is known about the characteristics of these clinical isolates in terms of 
basic biology, virulence and in vivo pathogenicity. The genetic variability of mycobacterial 
strains might lead to sharp phenotypic differences, which could be responsible for a 
differential modulation of host immune responses impacting in the onset and progression of 
the disease (Janulionis et al., 2005; Li et al., 2002). The underlying host-pathogen 
interactions that account for distinct clinical characteristics observed in patients suffering 
from M. avium infections are largely unknown. Previously, our group has showed that 
human neutrophils are able to phagocytize and kill the avian type strain, Mycobacterium 
avium TMC 724, in vitro (Hartmann et al., 2001). However, whether human neutrophils can 
kill M. avium isolated from human patients is not known.  In this study we used clinical 
isolates of M. avium hominissuis (SCH 228 and SCH 215). SCH 228 was isolated from the 
bone marrow of an AIDS patient suffering from disseminated M. avium infection while SCH 
215 originated from a toddler suffering from lymphadenitis coli. These strains are of 
differential virulence as shown by their highly differential growth rate in macrophages 
(Meyer et al., 1998). Here we have investigated how the differential virulence of these two 
human clinical isolates impacts on cell-autonomous immune regulation of neutrophils. 
3.1 Killing of M. avium 
The fact that human neutrophils could phagocytize and kill the avian type strain, 
Mycobacterium avium TMC 724, (Hartmann et al., 2001) led us to ask whether human 
neutrophils could kill human clinical M. avium hominissuis isolates, SCH 228 and SCH 215. 
Although human neutrophils kill TMC 724, they could not kill the SCH 228 and SCH 215 
(Fig.1). In particular there was no difference in bacterial uptake and survival within 
neutrophils between these two strains suggesting that virulence affects neutrophil 
autonomous defense. Several in vitro studies and animal infection models reveal that 
phylogenetic diversities among Mtb strains as well as non-tuberculous strains exhibit 
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different virulence and pathogenesis phenotypes in macrophages (Amaral et al., 2011; Lopez 
et al., 2003; Manabe et al., 2003; Manca et al., 2004; Manca et al., 2001; Palanisamy et al., 
2009; Vrba-Pech et al., 2013). It is thus likely that the clinical isolates SCH 228 and SCH 
215 that had been challenged in human patients may show different virulence and 
pathogenic phenotypes compared to TMC 724. Corleis et al. (2012) reported that human 
neutrophils phagocytize and kill M. smegmatis, a non-tuberculous mycobacteria within 3 h, 
supporting our previous published results where we showed that neutrophils were capable of 
killing non-tuberculous mycobacteria. Furthermore, they showed that though human 
neutrophils could phagocytize, virulence of Mtb type strain H37Rv impact the killing ability 
of the neutrophils. 
 
A protective role for neutrophils in mycobacterial infection in vivo has been addressed in 
mouse studies. Barrios-Payan et al. (2006) reported that granulocyte receptor 1 (GR-1) 
antibody-mediated depletion of granulocytes in mice before intratracheal infection with Mtb 
increases the number of CFU subsequently recovered from lungs and spleen. On the other 
hand, using similar antibody-mediated depletion of granulocytes, Seiler et al. (2000) showed 
that neutrophils have no effect on the bacterial burden of mice infected intravenously with 
106 CFU of Mtb, M. bovis BCG or the non-tuberculous strain M. fortuitum. However anti-
GR-1 is not specific for neutrophils. Thus the depletion of (Gr-1) positive cells may have off 
target effects such as targeting Ly6C on plasmacytoid dendritic cells (DCs), monocytes and 
CD8 positive T cells (Wojtasiak et al., 2010).  Overall studies addressing the killing capacity 
for neutrophils in vivo and in vitro provide controversial data that may be attributed to the 
high variability in the methods used.  
 
3.2 Phagosomal processing 
Virulent mycobacteria are able to survive and propagate inside macrophages by interfering 
with the phagosomal maturation process (Rohde et al., 2007a; Rohde et al., 2007b; Russell, 
2007; Russell et al., 2010a; Sweet et al., 2010). In macrophages, the sequential maturation of 
phagosomes including acidification is required for the fusion of lysosomes with phagosomes 
in order to kill pathogens (Cougoule et al., 2002; Deretic et al., 2006; Desjardins et al., 1994; 
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Nusse, 2011; Via et al., 1997; Vieira et al., 2002). Similarly, in neutrophils, maturation of 
phagosomes requires the fusion of granular contents with phagosomes prior to the fusion of 
lysosomes with phagosomes for digestion of pathogens (Nordenfelt and Tapper, 2011; 
Segal, 2005; Smith, 1994; Urban et al., 2006; Winterbourn et al., 2006; Winterbourn and 
Kettle, 2013). Phagosomal maturation can be studied using C12-FDG, as its fluorescence 
increases by the cleavage of galactopyranoside by β-galactosidase, a marker of lysosomal 
activity. This activity reflects the fusion of lysosomes with phagosomes and can be studied 
using flow cytometry (Robinson et al., 2008). In the present report, we have investigated 
whether phagosomal maturation in infected neutrophils was inhibited by these two clinical 
isolates. Fluorescence of C12-FDG coated mycobacteria did not increase at all till 5 h (Fig. 
2A and B) while the coated magnetic beads, the positive control, showed a clear shift in the 
fluorescence (Fig. 2C), indicating that fusion of lysosome with phagosomes is inhibited in 
neutrophils infected with these isolates. Our report is in agreement with many other studies 
(Cougoule et al., 2002; N'Diaye et al., 1998). N'Diaye et al. (1998) reported in their study 
that mycobacteria can uncouple phagocytosis from fusion of granules, especially azurophilic 
granules, which may potentially affect the maturation of phagosomes in infected neutrophils. 
Such inhibition of phagolysosomal fusion in infected macrophages is a key feature of 
mycobacterial survival (Deretic et al., 2006; Russell, 2001, 2007; Russell et al., 2010b). Mtb 
secretes protein tyrosine phosphatase (PtpA), to inhibit acidification of phagosomes, as a 
mechanism to prevent phago-lysosomal fusion (Wong et al., 2011). In addition to proteins 
associated with virulence, lipid components of the mycobacterial surface also contribute to 
the arrest of phagolysosome fusion in macrophages (Robinson et al., 2008; Russell, 2001; 
Russell et al., 2010b). Increased fluorescence of C12-FDG from heat-killed mycobacteria 
compared to that of C12-FDG coated live mycobacteria suggests that phagosomes 
containing heat-killed mycobacteria mature into phagolysosomes in infected neutrophils 
(Fig. 2D). Proteins associated with virulence of these isolates would have denatured upon 
heat inactivation but not lipid components. These lipid components may still play a role in 
inhibition of phago-lysosomal fusion. Even though the heat inactivated isolates showed 
increased fluorescence than viable bacteria, their shift in fluorescence is much lesser than 
that of coated beads.  These data also reflect the fact that lipid components of these isolates 
are able to inhibit phagosomal maturation. 
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3.3 Neutrophil activation 
Neutrophils mostly rely on toll-like receptors (TLRs) for their pathogen recognition 
capacities, and stimulation of these receptors usually leads to the activation MAPKs, PI3K, 
NF-κB, and AP-1 (Akira and Takeda, 2004; Aleman et al., 2004; Hayashi et al., 2003; 
Janssens and Beyaert, 2003; Parker et al., 2005; Prince et al., 2011; Sabroe et al., 2005). 
Regulation of neutrophil functions requires the activation of protein kinase C (PKC) and 
activation of protein tyrosine kinases (Perskvist et al., 2000; Smith, 1994). This activation 
leads to the phosphorylation-mediated activation of different phospholipases and kinases, 
e.g., Shc protein, phospholipase, PI3K, and MAPK (Perskvist et al., 2000; Sue et al., 1997; 
Zu et al., 1998). Importantly, these intracellular signals that are involved in neutrophil 
activation are potent modulators of neutrophil microbicidal responsiveness, such as ROS and 
granule secretion (Brumell et al., 1996; Sue et al., 1997). We found that both SCH 228 and 
SCH 215 dampened the activation of p38 MAPK in the early times of infection, but was 
later maintained at a moderate level at 2 h (Fig. 3). These data suggest that such an initial 
down regulation of p38 MAPK is the key evasion mechanism that may promote these 
isolates to survive in neutrophils by evading killing mechanisms such as ROS and 
degranulation. In fact, many studies have concluded that p38 MAPK plays an important role 
in the innate and adaptive immune response, and several studies have implicated p38 MAPK 
as a signaling target for mycobacterial infections (Peng et al., 2011; Reiling et al., 2001; 
Surewicz et al., 2004). Of note, these clinical M. avium isolates dampened p38 MAPK 
activation in neutrophils at least in the early time points, whereas, on the contrary others 
have shown that M. avium activates this pathway to interfere with killing by macrophages 
(Pathak et al., 2004; Tse et al., 2002; Yadav et al., 2004). Activation of p38 MAPK in 
infected macrophages leads to SOCS proteins (negative regulators of cytokine signaling)-
mediated manipulation of IFN-γ responses (Vazquez et al., 2006). Also, p38 MAPK 
mediated IL-10 expression influences the acidification of M. avium containing phagosomes 
(Fratti et al., 2003; Souza et al., 2007; Weiss et al., 2002). Binding of M. avium to TLR-2 is 
crucial for the p38 MAPK mediated suppression of antimicrobial responses within 
phagocytes (Weiss et al., 2008). Recently, it has been found that surface components of 
mycobacteria are involved in the manipulation of macrophage host defense mechanisms by 
differentially activating TLRs (Souza et al., 2013). Interestingly, initial transient activation 
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of p38 MAPK is a key mechanism that enables M. avium to survive in bovine monocytes 
(Fratti et al., 2003; Souza et al., 2007), whereas, in our study, it is the opposite, that is, initial 
down regulation of p38 MAPK activation in human neutrophils enables the survival of these 
two clinical M. avium isolates. It has been reported that such a limited activation of 
neutrophils by M. abscessus, a member of NTM enables the pathogen to promote its survival 
(Malcolm et al., 2013). This dichotomy in immune evasion of M. avium in neutrophils and 
macrophages can potentially be attributed to the modifications in the cell envelop 
components of mycobacteria such as glyco-peptidolipids, phenolic glycolipids, etc. 
(Brightbill et al., 1999; Robinson et al., 2008; Russell et al., 2010b; Sweet and Schorey, 
2006; Sweet et al., 2010; Sweet et al., 2008). 
 
3.4 Degranulation 
Secretion of granular contents into the pathogen containing phagosomes is instrumental for 
intra-phagosomal killing in neutrophils. However, neutrophil degranulation upon 
mycobacterial infection was not studied in detail till date. There are four types of granules 
present in the neutrophils; azurophilic, specific, gelatinase and secretory granules. Each of 
these granules has some components unique to themselves, whereas some others are present 
in other granules as well. Upon binding of pathogens to receptors, neutrophils initiate a first 
wave of granules release mainly from secretory granules (Bentwood and Henson, 1980; 
Faurschou and Borregaard, 2003; Lacy, 2006). These granules provide preformed receptors 
required on the surface of neutrophils for their activation. On further stimulation from the 
pathogen-TLR interactions, another wave of granule release happens. Engagement of 
pathogens with TLRs induces release of granules, which is mediated through p38 MAPK 
pathway (Appelberg, 2007; Binet and Girard, 2008; Mocsai et al., 2000; Sengelov et al., 
1993; Zhong et al., 2003). An inhibition of fusion of azurophilic granules with 
mycobacteria-containing phagosomes in neutrophils has been described and attributed to the 
inhibition of TLR2-Hck-p38 MAPK activation pathway (Mocsai et al., 2000; Mocsai et al., 
1999; N'Diaye et al., 1998). In our study we not only find a dampened p38 MAPK activation 
(Fig. 3) but also release of secretory granules does not exceed the amount that is induced 
upon fMLP stimulation of neutrophils that have been pretreated with a p38MAPK-inhibitor 
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(Fig. 4B). We conclude from these data that both clinical isolates, SCH 215 and SCH 228, 
dampen degranulation by inhibiting p38MAPK, which subsequently results in a 
compromised activation of neutrophils.  
Phagosomal killing of pathogens begins when contents from granules are fused with 
phagosomes, especially contents from both azurophilic and specific granules. Azurophilic 
granules contain lysosomal enzymes such myeloperoxidase (MPO), bactericidal 
permeability-increasing protein, defensins, cathepsin G (a family of serine proteases), 
neutrophil elastase and proteinase 3. Specific granules contain a battery of antimicrobial 
substances (e.g. alkaline phosphatases, collagenases, lactoferrin, lipocalin (NGAL), 
lysozyme, and hCAP18, the proform of LL-37). Contents from azurophilic as well as 
specific granules are released either into the phagosome or to the exterior of the cells 
(Borregaard, 2010; Borregaard et al., 2007; Faurschou and Borregaard, 2003). Here, we 
reported that both of these isolates inhibited the release of specific and secretory granules 
(Fig. 4). The release of azurophilic granules from mycobacteria infected neutrophils could 
neither be distinguished from uninfected nor from fMLP stimulated neutrophils. This may be 
due to the fact that these granules are low in abundance and are generally fused with the 
phagosomes. Our data suggest that one of the mechanisms by which both of these isolates 
evade killing by neutrophils is the inhibition of neutrophil degranulation.  
 
3.5 ROS 
We found that SCH 228 and SCH 215 clinical isolates induced differential ROS production 
in human neutrophils; SCH 215 induced significantly higher ROS levels than SCH 228 (Fig. 
5). Neutrophil NADPH oxidase (NOX-2) plays a key role in host defense and in 
inflammation by releasing large amounts of ROS (Dupre-Crochet et al., 2013). Upon 
activation by pathogens, neutrophils induce the assembly of NOX-2 complex on the 
phagosomal membrane, and, Rac-2 activation is important for this assembly. Activation of 
Rac-2 requires signals from TLRs and other pathogen recognizing receptors that involve 
protein tyrosine kinase activity. Also, production of ROS involves the activation of p38 
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MAPK (Makni-Maalej et al., 2013). Since, we observed that these two isolates differentially 
dampened the activation of p38 MAPK (Fig. 3), it was likely that they would induce 
differential ROS production in human neutrophils. Indeed, as expected, SCH 228 induced 
significantly lower levels of ROS as compared to SCH 215, due to its relatively higher 
efficiency in dampening the p38 MAPK activation (Fig. 5A). This was further confirmed by 
measuring ROS from neutrophils co-infected with both these isolates, where the level of 
ROS induction by SCH 215 was reduced in presence of SCH 228 (Fig. 5C). The significant 
reduction in ROS is not due to cell death, as the viability of cells was found to be more than 
85%, as determined microscopically by trypan blue staining of neutrophils. On one hand, 
one may postulate that owing to their differential envelop modifications, SCH 228 is able to 
reduce p38 MAPK-mediated ROS as compared to SCH 215. On the other hand, one may 
predict that SCH 228 hampers ROS induction because it is more susceptible and may be 
killed by ROS. However, in our hands, this was not the case: SCH 228 was not killed by 
neutrophils that are either activated by ROS-inducing fMLP or activated by exogenous ROS 
(data not shown). Even though, SCH 215 induced significantly higher levels of ROS in 
neutrophils, none of these isolates are killed (Fig. 1). These data suggest that these isolates 
have developed differential mechanisms to evade ROS-mediated killing. It has been 
demonstrated that glyco-peptidolipids from M. avium can scavenge ROS in macrophages 
(Scherer et al., 1997). Recently, McNamara et al. (2013) reported the proteomic 
characterization of surface exposed proteins from M. avium 104 , a clinical strain and 
reference strain of M. avium hominissuis and the identification of a surface exposed 
virulence associated protein, Cu-Zn SOD. Using a knockout strain, they suggested that a role 
for Cu-Zn SOD in the survival of M. avium in human neutrophils. Also, secretion of 
virulence factors from Mtb has been reported to have ROS scavenging functions in 
macrophages to prevent killing (Velmurugan et al., 2007).  Similar to our observation, 
Romero et al. (2012) reported that human clinical Mtb isolates showed differential abilities 
in inducing ROS in neutrophils. Whether ROS alone is sufficient to kill pathogens, is still 
under investigation (Dupre-Crochet et al., 2013; Mocsai, 2013; Parker et al., 2012). The fact 
that the significant difference in ROS induction comparing SCH 215 with SCH 228 has no 
impact on the bacterial survival of these two strains suggests that oxidative mechanisms 
have no role in the killing of these two particular clinical isolates.  
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The process of phagocytosis of pathogens by neutrophils is accompanied by release of ROS 
at high levels, a feature known as respiratory burst. After formation of phagosomes, ROS 
has to return to basal levels in order for the phagosomes to acidify (Segal, 2005). If ROS 
accumulates in the phagosomes, it would consume considerable amount of protons, which 
are pumped into and required for acidification of the phagosomes. This would consequently 
increase the pH of the phagosomes (Winterbourn and Kettle, 2013). In order to employ 
acidification of the phagosomes, ROS is assimilated or scavenged by anti-oxidant systems 
such as super oxide dismutase (SOD). Upon scavenging of ROS, the pH drops gradually due 
to movement of various ions into the phagosomes. This acidification is essential for the 
fusion of various granules and lysosomes with phagosomes for efficient killing of pathogens 
(Segal, 2005; Winterbourn et al., 2006; Winterbourn and Kettle, 2013). In fact for 
macrophages it has been shown that increase in the intracellular levels of glutathione (GSH), 
another ROS scavenger, reduced levels of free radicals in macrophages and thereby, 
increased the acidification of Mtb containing phagosomes resulting in effective killing of 
Mtb Morris et al. (2013).  
Our ROS kinetics revealed that for these two isolates even when ROS declines after having 
reached its peak concentration, it never falls to basal levels but is induced in moderate 
amounts in neutrophils up to 4 h of infection (Fig. 5A). It is possible that this continuous 
low-level induction of ROS throughout the infection prevents acidification of mycobacteria-
containing phagosomes, however, this hypothesis needs further proof.  
 
3.6 Cytokines 
Induction of cytokines upon pathogen binding to TLRs is mediated by p38 MAPK (Makni-
Maalej et al., 2013; Zu et al., 1996; Zu et al., 1998). As predicted, neutrophils infected with 
M. avium hominissuis SCH 215 and SCH 228 clinical isolates, did not induce most of the 
cytokines known to be released upon neutrophil activation. However, we observed 
differential induction of IL-8 and IL-1ra, SCH 228 being the least inducer of these cytokines 
(Fig. 6), and this correlates with the differential inhibition in p38 MAPK activation by these 
two isolates (Fig. 3). Importantly, these two isolates literally abolished induction of pro-
	   67	  
inflammatory cytokines such as TNF- α, IFN- γ, IL-6 and IL-1 β, presumably by dampening 
TLR2-p38 MAPK pathway. It has been reported that activation through TLR and p38 
MAPK is important for many functions including production of pro-inflammatory cytokines 
in immune cells. (Trinchieri and Sher, 2007; Zu et al., 1996; Zu et al., 1998). One may 
propose that induction of anti-inflammatory cytokines, such as, IL-10, inhibited the pro-
inflammatory cytokine production in neutrophils infected with these isolates. However, this 
is not the case, as these isolates did not induce IL-10 production as well. Type strain Mtb has 
been shown to induce lower levels of TNF-α, IL-6 andIL-8 in human neutrophils than NTM 
(Faldt et al., 2002). Portevin et al. (2011) reported that clinical isolates of Mtb showed 
variation in the induction of pro-inflammatory cytokines and chemokines in macrophages. 
Others have shown that M. avium. hominissuis induced more of anti-inflammatory and less 
of pro-inflammatory cytokines in human macrophages when compared to M. avium avium 
(Thegerstrom et al., 2012).  
The fact that in the time line of neutrophil infection with our two strains ROS is released 
earlier than IL-8, suggests that in addition to p38 MAPK, ROS may also be involved in the 
induction of IL-8. Indeed, we could show by using a ROS scavenger, SOD, that ROS is 
involved in the induction of IL-8 (Fig. 7B). The involvement of ROS in IL-8 induction 
indicates that it may be acting as a signaling molecule. Our experiments with exogenous 
addition of ROS confirmed the role of ROS as a signaling molecule (Fig. 7C). Furthermore 
inhibition of p38MAPK, significantly reduced ROS (Fig.5B) as well as IL8 release (Fig. 7A) 
from neutrophils infected with either of our two clinical isolates. Together, our data indicate 
that p38 MAPK and ROS are involved in the induction of IL-8 in neutrophils infected with 
SCH 215 and SCH 228. In fact, it is known that as a signaling molecule, oxidative stress by 
ROS can activate MAPKs, including p38 MAPK. However, the mechanisms by which ROS 
can activate these kinases are unclear. It is also not clear where ROS is located and where 
ROS binds to exert their signaling functions including p38 MAPK activation (D'Autreaux 
and Toledano, 2007; Finkel, 2011; Son et al., 2011; Tonks, 2005). As mentioned above, both 
isolates maintained ROS induction on low levels even after declining from its peak 
concentration and still ROS had no impact on survival of these isolates. Presumably a 
sustained induction of ROS would maintain the activation of various MAPKs, including p38.  
	   68	  
Our western blot results show that, these isolates dampened the receptor-mediated p38 
MAPK activation, which can be appreciated from 15 min p.i (Fig. 3). The fact that the ROS 
induction is delayed till 30 min and p38 MAPK activation was restored gradually after 2 h, 
suggest that ROS may be involved in the activation of p38 MAPK later in the time course of 
infection. Recently, many reports have described the involvement of ROS-mediated p38 
MAPK activation in cytokine induction, including IL-8 (Boggaram et al., 2013; Lee et al., 
2009; Liu et al., 2014; Mitra and Abraham, 2006). Treatment of neutrophils with IL-8, 
which binds to CXCR1/2 receptors, induces release of the granules including azurophilic 
granules (Fig. 8), which reflects the fact that activation of receptor-mediated p38 MAPK is 
required for the efficient release of granular contents. However, activation of neutrophils 
with either IL-8 (data not shown) or the TLR 4 agonist LPS, did not affect the killing 
capacity of human neutrophils (Fig. 9), highlighting the fact that these clinical M. avium 
strains down regulate the activation of receptor-mediated p38 MAPK which is required for 
killing in human neutrophils. These data collectively indicate that activation of receptor-
mediated p38 MAPK is actually detrimental to the survival of these isolates in neutrophils 
but not the ROS-mediated p38 activation. Extrapolating this data may suggest that ROS as a 
signaling molecule may not bind to TLR receptor to activate p38 MAPK. 
 
3.7 Cell death 
Prevention of pathogen induced cell death is part of the immune evasion mechanisms of 
these isolates in neutrophils. We observed that these isolates neither induced apoptosis nor 
necrosis (Fig. 10). It has been postulated that apoptotic neutrophils containing mycobacteria 
may induce pro-inflammatory response in macrophages upon internalization (Aleman et al., 
2007; Krysko et al., 2006; Martin et al., 2014; Molloy et al., 1994). Neutrophils undergoing 
non-pathogen induced apoptotic cell death do not induce pro-inflammatory responses in 
macrophages. From our studies, we observed that neutrophils infected with these isolates 
neither induced pro-inflammatory cytokines, (except IL-8) nor, induced cell death. IL-8 may 
function as anti-apoptotic agent as it has been proposed by others (Dunican et al., 2000a; 
Dunican et al., 2000b) or it may just attract macrophages to the site of dead cells in order to 
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be able to scan for ‘eat me’ signal (Gardai et al., 2006; Ravichandran, 2011). These 
observations together point to the presumed concept that neutrophils act as ‘Trojan horses’ 
for virulent mycobacteria. In general, efficient killing of mycobacteria could allow 
neutrophils to prevent infection at an early stage. However, when killing is not efficient, 
infected neutrophils may transport pathogens to distant sites through circulation (Abadie et 
al., 2005; Eruslanov et al., 2005; Eum et al., 2010). 
The ways by which mycobacteria alter the defense mechanisms of neutrophils still remain 
largely unknown. There are three ways known by which neutrophils can kill intracellular 
pathogens; production of ROS, release of various granular contents and finally, formation of 
NET, the in vivo function of the latter is yet to be confirmed (Borregaard, 2010; Brinkmann 
et al., 2004; Hager et al., 2010; Nathan, 2006; Segal, 2005). Based on our study, we propose 
a model of intracellular survival whereby these M. avium clinical isolates exploit the host 
defense responses and promote its own survival. Both these isolates prevent the activation of 
neutrophils that involves the p38 MAPK pathway. Inhibition of the release of granules into 
phagosomes promotes survival of the pathogens in spite of differential ROS induction. 
Limited activation of neutrophils prevents it from pathogen induced-apoptosis, thereby, 
allowing them to act as Trojan horses, ultimately, engulfed by the primary host, the 
macrophage.  
 
3.8 Extracellular killing 
Upon activation by pathogens or receptor ligands, neutrophils release granular contents into 
phagosomes and antimicrobial molecules of the granules contribute to the killing of intra 
phagosomal-pathogens. In addition to release into the phagosomes, these contents are 
secreted out of the cell, and it is thought that they may contribute to the extra cellular killing 
of pathogens. However, such extracellular killing ability of neutrophils in the context of 
mycobacteria still remains to be studied. We hypothesized that pathogen-specific stimulation 
of neutrophils may influence the contents of granular release, and thereby, their killing 
capacity of extracellular pathogens. It is known that neutrophils can be artificially stimulated 
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with a combination of a fungal soluble factor cytochalsin B (cytB) and formylated-peptide, 
fMLP to degranulate both azurophilic and specific granules (Bentwood and Henson, 1980; 
Mitchell et al., 2008; Standish and Weiser, 2009; Zarember et al., 2007).  
We found that such an artificial stimulation of neutrophils resulted in enhanced release of 
both azurophilic and specific granules into the supernatant, but not secretory vesicles, as 
expected (Fig. 11A-C). Interestingly, we observed that this supernatant was able to inhibit 
the growth of both isolates in cell free-medium (Fig. 11D and E). The ability of granular 
contents in inhibiting mycobacterial growth in culture medium was reported earlier (Borelli 
et al., 1999; Halaas et al., 2010; Jena et al., 2012; Martineau et al., 2007; Sonawane et al., 
2011). Martineau et al. (2007) showed that human neutrophil peptides 1-3, cathelicidin LL-
37 and lipocalin 2 are capable of killing Mtb in culture medium. In addition, they reported 
that both cathelicidin LL-37 and lipocalin 2 inhibited growth of the organism, the latter in an 
iron-dependent manner. Jena et al. (2012) demonstrated that azurophilic components are able 
to kill mycobacteria in culture medium by disintegrating the bacterial membrane. However, 
how these antimicrobial molecules are regulated and secreted in neutrophils is not clearly 
known. More importantly, whether or not the secretion of these potential antimycobacterial 
molecules in infected neutrophils is affected by mycobacteria is not analyzed till this date. 
Although neutrophils activated by cytB/fMLP retain the degranulation mediated ability in 
controlling extracellular growth of SCH 228/215 (Fig. 11D and E), degranulation of 
neutrophils infected with these isolates is very much reduced due to the inhibition of 
neutrophils activation. Therefore, it is likely that the supernatant from infected neutrophils 
may not be able to inhibit the extra cellular growth of these isolates. As we expected, 
supernatants from SCH 228/215-infected neutrophils failed to inhibit extra cellular growth 
of these isolates (SCH 228/215) (Fig. 12A and B). Due to the differential activation of 
neutrophils by these two isolates, components of granules that are released in the supernatant 
may vary from each other and from that of cytB/fMLP-stimulated supernatant. This limited 
activation of neutrophils by these isolates may have enabled the cells to secrete only few or 
certain antimicrobial molecules into the extra cellular mileu. In this line, we could 
demonstrate that the contents of supernatant from neutrophils obtained upon stimulation 
with potent activators, cytB/fMLP, could actually inhibit the extra cellular growth of these 
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isolates, but not S. aureus (SA) (Fig. 12C and D). On the other hand, strikingly, SCH 
228/215-stimulated supernatants showed differential but significant inhibition of SA growth 
(Fig. 12C and D), which correlated with differential activation of neutrophils by these 
isolates. Our data suggest that pathogen induced receptor-mediated activation of neutrophils 
is important not only for intra-phagosomal killing but also, for extracellular killing. In 
addition, our data suggest that the level of activation of neutrophils may play a role in 
dictating the composition of the granular contents that are released from neutrophils. This 
difference in the composition of granular contents may either be due to different levels of 
expression of proteins, or simply due to the presence or absence of certain proteins. It is 
interesting to notice that mycobacteria induced supernatant of neutrophils inhibited extra 
cellular growth of SA, suggesting these supernatants might be able to control a secondary 
infection by SA in an in vivo scenario. It has been reported that the oxidative killing 
mechanism of neutrophils is involved in killing of SA (Selva et al., 2009; Standish and 
Weiser, 2009). However, based on our extra cellular growth inhibition data, we suggest that 
non-oxidative killing mechanism of neutrophils involving release of granules may also play 
a role in SA killing. This has also been shown by other groups (Corbin et al., 2008; Hermann 
et al., 1990). Animal studies have shown that elastase and cathepsin G are important for the 
in vivo clearance of SA (Belaaouaj et al., 1998; Reeves et al., 2002). iTRAQ labeling and 
mass spec identification of proteins present in the supernatants from neutrophils, either 
stimulated with cytB/fMLP or infected with these mycobacteria, may shed light on how 
these supernatants vary in their functions. Such analysis would help us to identify the 
specific proteins that are responsible for inhibition of these clinical isolates and may open up 
avenues for use in therapeutic application in mycobacterial diseases. 
 
3.9 Neutrophil-macrophage interaction 
Neutrophils and macrophages are phagocytic cells that cooperate during inflammation and 
tissue repair, in addition to cell homeostasis (Silva, 2010a, b). Neutrophils provide the first 
line of defense against infection. However, their prolonged activation leads to tissue injury. 
Neutrophils undergo constitutive apoptosis and are engulfed by tissue macrophages or 
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monocytes in order to maintain neutrophil homeostasis (deCathelineau and Henson, 2003). 
During infection, pathogens may induce apoptosis in neutrophils. Clearance of apoptotic 
neutrophils can result in either suppression or stimulation of pro-inflammatory responses in 
engulfing macrophages, which may modulate macrophage activation and microbicidal 
activity (Lucas et al., 2003; Torchinsky et al., 2009; Zheng et al., 2004). Many studies have 
suggested that neutrophil-macrophage interaction may contribute to host defense against 
mycobacterial infection (Jena et al., 2012; Tan et al., 2006). Activation of both neutrophils 
and macrophages is important for this response. However, such investigation of neutrophil-
macrophage interaction towards the control of mycobacterial growth was not yet done using 
human M. avium isolates. Our co-culture experiments demonstrated that the addition of 
naïve or LPS-stimulated neutrophils did not affect the intracellular survival of these human 
isolates in infected human macrophages (Fig. 13). This suggests that these isolates may 
prevent the interaction between neutrophils and macrophages thereby preventing the control 
of infection. 
In addition to cytokines and chemokines, granular contents are released from neutrophils that 
contribute to the control of mycobacterial infection in macrophages (Soehnlein et al., 2009). 
Also, we have shown that granular contents from neutrophils are capable of inhibiting the 
growth of mycobacteria. However, the role of pathogen induced degranulation in the 
interaction between neutrophils and macrophages towards the control of mycobacteria is not 
investigated till this date. Here, using non-contact co-culture experiments, we showed that 
the addition of degranulated supernatant from either uninfected neutrophils or mycobacteria-
infected neutrophils to infected macrophages did not affect the bacterial burden in the 
macrophages (Fig. 14). This may be due to the fact that the degranulation in infected 
neutrophils is inhibited by these mycobacterial isolates.  
Neutrophils are attracted to the site of infection by infected macrophages. They need further 
activation from infected macrophages to exert their immune responses. It has been shown 
that contents from neutrophil granules are able to activate macrophages towards the control 
of mycobacterial infection (Ribeiro-Gomes et al., 2007; Soehnlein et al., 2009; Sonawane et 
al., 2011). However, whether infected macrophages influence the degranulation of infiltrated 
neutrophils is not studied so far. Our degranulation kinetics study showed that macrophages 
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infected with these isolates induced exocytosis of specific/gelatinase granules predominantly 
in naïve neutrophils and did not induce azurophilic and secretory granules (Fig. 15). These 
data suggest that mycobacteria infected macrophages prevent degranulation of azurophilic 
and secretory granules and induce specific/gelatinase granules in naïve unstimulated 
neutrophils. Exocytosis of secretory vesicles is required for the expression of receptors in the 
surface that are in turn required for the complete activation of neutrophils. Also, contents of 
azurophilic granules such as myeloperoxidase, defensins, neutrophil elastase, serine 
proteases etc., are shown to be involved in the activation of macrophages towards the control 
of mycobacteria. By preventing azurophilic and secretory granules release, these human 
isolates could possibly prevent activation of both unstimulated neutrophils and infected 
macrophages, thereby, sabotaging the outcome of the interaction between neutrophils and 
macrophages. Specific/gelatinase granules contain many tissue-degrading enzymes called 
matrix metalloproteinase (MMPs). The MMP family of enzymes contributes to both normal 
and pathological tissue remodeling. They have been shown to play a role in the migration of 
normal and malignant cells through the body. It was reported that in tuberculosis matrix 
metalloproteinase-1 is regulated by a p38 MAPK-dependent mechanism (Rand et al., 2009). 
In our study we observed predominant exocytosis of specific/gelatinase granules from naïve-
uninfected neutrophils induced by SCH 228/215 M. avium-infected macrophages. This result 
suggests that degranulation of specific/gelatinase granules may lead to the further 
accumulation of immune cells including monocytes, T cells and neutrophils, which are 
necessary for the formation of granuloma around the infected macrophages. 
 
3.10 Chemotaxis 
Mycobacteria infected macrophages attract neutrophils to the site of infection by releasing 
cell mediators. The mechanisms by which neutrophils are attracted to the site of 
mycobacterial infection are not fully characterized. Lowe et al. (2012) have summarized the 
possible cell mediators that may be involved in neutrophil chemo attraction. We have 
previously shown that in addition to the well known cytokines and chemokines, infected 
macrophages release particles associated with HSP-70 that are chemoattractive to 
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neutrophils (Hartmann, 2006). In this study we have identified these particles as exosomes 
that are known to act as molecule carriers during immune cell-cell communication 
(Gutierrez-Vazquez et al., 2013). We showed that exosomes isolated from mycobacteria-
infected THP macrophages attracted human neutrophils (Fig. 17). This data suggest that 
exosomes from mycobacteria-infected macrophages may be carriers of molecules that can 
attract neutrophils. Singh et al. (2012) demonstrated that in trans-well cell migration assay 
exosomes from Mtb H37Rv-infected macrophages could induce migration of macrophages, 
neutrophils and T cells from mouse splenocytes when compared to exosomes from 
uninfected macrophages. Furthermore, it has been reported that certain mycobacterial lipid 
components are released through exosomes and such pathogen-associated molecules may 
play a role in suppression of host immune response, probably by suppressing IFN- γ 
mediated activation of macrophages (Singh et al., 2011). However, one cannot rule out the 
possibility that the host factors present in or on the surface of the exosomes can also attract 
neutrophils, in addition to mycobacterial components. Analysis of our mass spec data from 
exosomes resulted in identifying putative proteins that may be involved in the 
chemoattraction of neutrophils (Table 2). In addition to the host proteins, we also observed 
that some bacterial proteins were present in those exosomes (Table 1). Since, proteins of 
these clinical strains were not characterized previously, we have restricted our similarity 
search to the genus, Mycobacterium. Since it is likely that the amount of mycobacterial 
antigens that might be present in exosomes from infected macrophages is lower than that 
present in mycobacteria itself, we therefore focused on the host factors that may be involved 
in the neutrophil chemoattraction.  
 
3.11 Exosomes and their components as potential chemoattractants 
The identification of the protein and lipid composition of exosomes may provide an insight 
into possible functions of these extracellular vesicles and how these molecules act in 
mycobacterial infection in granuloma. Here, as an example, we have focused on galectins 
due to the fact that it has been shown to be a potential chemotactic factor secreted via 
exosomes, that may be responsible for neutrophil chemotaxis (Gonzales et al., 2009; 
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Gonzalez-Begne et al., 2009; Koumangoye et al., 2011; Welton et al., 2010). 
Galectins (Gal) are a family of proteins with the ability of binding to β-galactosides. To date, 
15 members have been identified which differ in structure and in terms of the multivalent 
interactions they can establish with specific glycosidic structures. However, all galectins 
contain conserved carbohydrate-recognition domains (CRDs) of about 130 amino acids. In 
mammals, galectins are widely expressed by normal and pathological tissues. Due to their 
lack of signal sequence, galectins are thought to be secreted through a non-classical pathway 
(Hughes, 1999). In fact, secretion of galectins via the exosome pathway has been shown 
recently (Gonzales et al., 2009; Gonzalez-Begne et al., 2009; Koumangoye et al., 2011; 
Welton et al., 2010). Galectins also exist in the nucleus (Liu et al., 2002). Extracellularly, 
galectins can bind to cell-surface glycoconjugates that contain suitable galactose-containing 
oligosaccharides and glycoproteins in the extracellular matrices, such as laminin, fibronectin 
and elastin. Crosslinking of cell-surface glycoconjugates with galectins can trigger a cascade 
of transmembrane signaling events. Because of these binding abilities, galectins operate as 
readers of the glycocodes for leukocytes (Leffler et al., 2004). A diverse range of biological 
functions involved in immune and inflammatory responses and tumor development have 
been reported for galectins over the last decade, including roles in modulating cell–matrix 
interactions, trafficking, cytokine secretion, proliferation and survival, thus placing galectins 
into a growing list of important regulatory elements of immunity (Elola et al., 2007; 
Rabinovich et al., 2004; Yang et al., 2008) 
Interestingly, we have found Gal-1, 3 and 9 to be present in the exosomes from infected 
macrophages (Table 1). Gal-1 and Gal-3 are probably the most ubiquitously expressed 
members of the galectin family. Gal-1 has been found to regulate multiple facets of adaptive 
and innate immune responses (Kuwabara et al., 2003; Norling et al., 2009; Rabinovich et al., 
2002). Auvynet et al. (2013) showed that galectin-1 is a chemo attractant for neutrophils. 
Gal-1 is not exclusively chemotactic for neutrophils, as it has also been shown to influence 
the migration of dendritic cells and monocytes (Fulcher et al., 2009; Malik et al., 2009). It 
inhibits the release of inflammatory mediators from neutrophils (Rabinovich et al., 2000).  
Other galectins including Gal-3 and Gal-9 can also regulate the immune and inflammatory 
responses. Gal-3 has been shown to function as a chemoattractant for monocytes, 
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macrophages and neutrophils (Bhaumik et al., 2013; Nieminen et al., 2008; Sano et al., 
2000).  Similar to Gal-1 and Gal-3, Gal-9 can also induce T cell apoptosis (Fukumori et al., 
2003). Gal-9 has been characterized a chemoattractant for monocytes, macrophages and 
eosinophils (Hirashima, 2000; Kuwabara et al., 2003; Nieminen et al., 2008). Given such 
functions attributed to Gal-1, 3 and 9, this makes galectins a very interesting candidate for 
our further studies regarding the function of exosomes as a potential chemoattractants.  
In this study we used two clinical strains of M. avium hominissuis, SCH 228 and SCH 215 
that have been previously characterized to be differential with regard to their generation time 
within macrophages as a feature of mycobacterial virulence. Such variation in virulence may 
be responsible for differences in disease outcome. We tried to understand the cell 
autonomous functions of neutrophils in mycobacterial infection and also how clinical M. 
avium strains considered of high and low virulence regulate such capacities of neutrophils in 
the evolutionary arms race. Our study demonstrates that SCH 228 and SCH 215 limit the 
activation of human neutrophils by differentially down regulating the activation of p38 
MAPK pathway. Such differential regulations promote bacterial survival by impeding the 
p38 MAPK-mediated immune functions such as ROS, degranulation and cytokine induction 
in neutrophils. To the best of our knowledge, this is the first report on the human 
neutrophils’ autonomous defense mechanisms and how human clinical M. avium strains 
affect them. The virulence based differential regulation of p38 MAPK mediated immune 
functions of human neutrophils may account for differences in the pathogenesis. Now it is 
becoming clear that in addition to host factors, phenotypic differences among different 
strains of mycobacteria are also involved in key aspects of pathogenesis. Moreover, this 
study underscores degranulation as a key function of neutrophils in limiting extracellular M. 
avium growth. As a future perspective, it is certainly worthwhile to do extensive comparative 
proteomic analyses of cytB/fMLP and M. avium stimulated supernatants from neutrophils in 
order to pin point possible factors that might be able to control M. avium infection. Finally, 
this study has also opened up new avenues to pursue certain unanswered questions regarding 
the functions of exosomes as potential chemoattractants as well as immune modulators in 
mycobacterial infection.  
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4 Summary 
Neutrophils are phagocytes that are known to be fast responders and reach the site of an 
infection as an innate immune response. Neutrophils, in addition to monocytes and 
macrophages, have been implicated during the initial phase of mycobacterial infection. 
However, neutrophils are less well studied than other components of the host response to 
mycobacteria such as the macrophages, the natural primary host cell and T cells. Whether 
neutrophils are able to actively kill mycobacteria and thus contribute to mycobacterial 
clearance remains controversial. Our group has shown that human neutrophils are able to 
phagocytize and kill the avian type strain Mycobacterium avium TMC 724 (M. avium) in 
vitro. In this study we used two clinical strains of M. avium hominissuis, SCH 228 and SCH 
215 that have been previously characterized to be differential with regard to their generation 
time within macrophages as a feature of mycobacterial virulence. Such variation in virulence 
may be responsible for differences in disease outcome. Here we tried to understand the cell 
autonomous functions of neutrophils in mycobacterial infection and also how clinical 
isolates of M. avium hominissuis (SCH 228 and SCH 215) considered of high and low 
virulence impact on neutrophil functional capacities.  Our study demonstrates that SCH 228 
and SCH 215 limit the activation of human neutrophils by differentially down regulating the 
activation of p38 MAPK pathway. Such differential regulations promote bacterial survival 
by impeding the p38 MAPK-mediated immune functions such as ROS, degranulation and 
cytokine induction in neutrophils. To best of our knowledge, this is the first report on how 
the virulence of clinical M. avium hominissuis isolates impacts on various innate immune 
functions of human neutrophils. We also demonstrated the ability of degranulation from 
cytB/fMLP-activated human neutrophils in controlling the extracellular growth of clinical 
M. avium hominissuis isolates, SCH 228 and SCH 215. Furthermore, the degranulated 
supernatants from neutrophils infected with these isolates show the capacity to inhibit 
extracellular growth of Staphylococcus aureus whereas they have no bactericidal effect on 
SCH 228 and SCH 215 themselves.  
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Investigation of neutrophil-macrophage interaction in the defense of these clinical M. avium 
isolates revealed that neither naïve nor LPS-stimulated neutrophils when co-cultured with 
infected human macrophages did impact on intra-macrophage bacterial survival of SCH 228 
and SCH 215. However, macrophages infected with these isolates induce predominantly 
degranulation of specific/gelatinase granules in naïve neutrophils, indicating that neutrophil-
macrophage interaction impacts on the microenvironment of local infection thereby 
potentially contributing to disease pathogenesis. Furthermore, this study underscores the 
importance of exosomes released from macrophages infected with M. avium as a cell-
mediator molecule involved in the interaction of infected macrophages with other immune 
cells, as these exosomes attract human neutrophils. As a perspective, our finding that 
cytB/fMLP stimulated degranulation controls the extracellular growth of clinical M. avium 
hominissuis isolates, SCH 228 and SCH 215, encourages us to further carry out extensive 
comparative proteomic analyses of cytB/fMLP and M. avium stimulated supernatants from 
neutrophils in order to identify possible factors that might be able to control M. avium 
infection and may qualify as potential anti-mycobacterial drugs. Also, proteomic analysis of 
exosomes from infected macrophages suggests follow-up studies to identify the potential 
chemoattractive factors for neutrophils. This would allow one to study the role of such 
factor(s) present in the exosomes in the interaction of infected macrophages and neutrophils, 
and possibly, other immune cells. 
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5 Zusammenfassung 
 
Mykobakterien stellen als humanpathogene Erreger weltweit eine Bedrohung dar. Allein 
Mycobacterium  tuberculosis (Mtb) war im Jahr 2012 für 1.3 Millionen Tote und 8.6 
Millionen Primär- bzw. reaktivierte Infektionen verantwortlich. Nicht tuberkulöse 
Mykobakterien (NTM), wie die Vertreter des Mycobacterium avium complex (MAC) sind 
opportunistische Keime bei immunsupprimierten Individuen. Seine größte Bedeutung 
erlangte M. avium im Rahmen der AIDS-Pandemie als lebensbedrohlicher Erreger bei HIV-
infizierten Patienten. Nach einem, durch die Einführung der hochaktiven antiretroviralen 
Therapie (HAART) bedingten, Rückgang der Inzidenz Ende der 90er Jahre wird aktuell eine 
Renaissance von MAC Infektionen in der HIV-infizierten Population der westlichen Welt 
beobachtet. Darüber hinaus steigt die Inzidenz von MAC Infektionen auch bei 
immunkompetenten Patienten, insbesondere den Älteren, bei denen sich Infektionen der 
Lunge auf dem Boden einer pulmonalen Prädisposition manifestieren, die mit einer hohen 
Mortalität einhergehen.  
M. avium ist ein fakultativ intrazellulärer Erreger, dem vorzugsweise Makrophagen und 
Monozyten als Wirtszellen dienen, der aber auch in nicht professionellen Phagozyten 
persistieren kann. Neutrophile Granulozyten sind die erste Linie der Verteidigung gegen 
mikrobielle Pathogene, dennoch wurde ihnen lange Zeit keine Bedeutung bei Infektionen 
mit intrazellulären Erregern zugeschrieben. Neuere Untersuchungen in Tiermodellen, in 
vitro Studien mit humanen Granulozyten sowie klinische Beobachtungen lieferten Hinweise 
darauf, dass Neutrophile einen direkten Beitrag zur Eliminierung von Mykobakterien leisten. 
Die Bedeutung dieses Beitrages und seine Einordnung in den Hintergrund der bisher 
bekannten Patho- und Immunmechanismen für Mykobakteriosen sind ungeklärt. In 
Untersuchungen, die dieser Arbeit vorausgingen, konnten wir zeigen, dass der aviäre 
Typstamm Mycobacterium avium TMC 724 (M. avium) durch neutrophile Granulozyten in 
vitro effektiv eliminiert wird. Virulente Mykobakterien können in Makrophagen einen 
phagosomalen Arrest verursachen, der ihre Degradierung im Phagolysosom verhindert. 
Somit können virulente Mykobakterien den Makrophagen als Wirtzelle nutzen und sich 
ungehindert replizieren. In dieser Studie haben wir zwei klinische Isolate von M. avium 
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hominissuis (SCH 228 und SCH 215) eingesetzt, die vormals basierend auf ihrer 
Generationszeit im Makrophagen als hoch und niedrig virulent charakterisiert wurden. 
Derartige Virulenzunterschiede werden mutmaßlich für unterschiedliche Krankheitsverläufe 
verantwortlich gemacht. Wir haben untersucht, welchen Einfluss die unterschiedlich 
Virulenz dieser klinischen Isolate von M. avium hominissuis (SCH 228 and SCH 215) auf 
die funktionellen Eigenschaften von neutrophilen Granulozyten hat.  Wir konnten zeigen, 
dass SCH 228 und SCH 215 nicht durch humane Neutrophile abgetötet werden, und dass 
beide Stämme den Prozess der Phagosomenreifung blockieren. Intrazelluläre Abtötung von 
Pathogenen durch Neutrophile und die Induktion der dafür notwendigen Prozesse, wie 
Degranulation und Freisetzung von ROS und Zytokinen ist unmittelbar mit einer 
Aktivierung des p38 MAPK Signalweges assoziiert.  In Western Blot Analysen konnten wir 
zeigen, dass beide Isolate p38 MAPK herunterregulieren, wobei SCH 228 p38 MAPK für 
bis zu 60 min nahezu vollständig abschaltet, während SCH 215 eine moderatere 
Abschwächung der Aktivierung von p38 MAPK verursacht. Diese differentielle Induktion 
von p38 MAPK durch die beiden Isolate führt nach ihrer Phagozytose durch humane 
Neutrophile zu einem unterschiedlichen Aktivierungsmuster hinsichtlich Degranulation, 
ROS- und Zytokinfreisetzung. So induziert das niedrig virulente Isolat, SCH 215, 8-10 mal 
soviel ROS wie das hoch virulente Isolat SCH 228. Wir konnten ferner zeigen, dass die 
cytB/fMLP aktivierte Degranulation von humanen Neutrophilen einen bakteriostatischen 
Effekt auf das extrazelluläre Wachstum von beiden klinischen M. avium hominissuis Isolaten 
hat. Darüber hinaus haben die degranulierten Überstände von Neutrophilen nach Infektion 
mit SCH 228 und SCH 215 einen differentiellen bakteriziden Effekt auf Staphylococcus 
aureus, wohingegen sie das extrazelluläre Wachstum von SCH 228 und SCH 215 selbst 
nicht beeinflussen. Die Untersuchung der Interaktion von Makrophagen und Neutrophilen in 
Ko-Kultur Experimenten zeigte, dass weder naive noch LPS-stimulierte Neutrophile einen 
Einfluss auf das intrazelluläre Überleben von SCH 228 und SCH 215 im Makrophagen 
hatten. Allerdings induzierten M. avium hominissuis infizierte Makrophagen die 
Degranulation naiver neutrophiler Granulozyten mit einer Prädominanz von 
spezifischen/Gelatinase Granula. Dies impliziert, dass die Interaktion von Neutrophilen mit 
Makrophagen in der Immunabwehr von M. avium hominissuis einen Einfluss auf die lokale 
Mikro-Umgebung nimmt, der potentiell zur Pathogenese der Infektion beiträgt. Im Bezug 
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auf die Makrophagen-Neutrophilen-Interaktion unterstreichen unsere Ergebnisse die 
Bedeutung von Exosomen, die nach Infektion von Makrophagen mit M. avium hominissuis 
freigesetzt werden, als zelluläre Mediatoren, da diese Exosomen direkte Chemoattraktanten 
für Neutrophile sind. Die Tatsache, dass die cytB/fMLP induzierte Degranulation von 
Neutrophilen einen bakteriostatischen Effekt auf das extrazelluläre Überleben von klinischen 
M. avium hominissuis Isolaten hat, erlaubt als Ausblick dieses Projektes die vergleichende 
Proteom-Analyse von cytB/fMLP und M. avium stimulierten Überständen zur 
Identifizierung potentieller Faktoren, die für diesen bakteriostatischen Effekt verantwortlich 
zeichnen. Ferner kann die  Proteom-Analyse der Exosomen von infizierten  Makrophagen 
potentielle Chemoattraktanten für Neutrophile identifizieren, deren Rolle in der Interaktion 
von infizierten Makrophagen mit Neutrophilen und möglicherweise anderen Immunzellen in 
der Folge untersucht werden könnte.  
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6 Materials and methods 
6.1 Materials 
6.1.1 Instruments 
Items       Company, Place 
 
Autoclave       Fritz Gössner Gmbh, Hamburg 
Blotting chamber Criterion    Bio-Rad, Munich 
Centrifuge  
3 S-R       Heraeus, Hanau 
J-6B       Beckman, USA 
Multifuge 4KR      Heraeus, Hanau 
Biofuge fresco, Tabletop    Heraeus, Hanau 
Centrifuge rotors, max. 4600 rpm   Heraeus, Hanau 
Constant cell disruption systems   IUL Instruments, Königswinter, Germany 
Electrophoresis power supply,  
PowerPac-300     Bio-Rad, Munich 
Fluorescent Activated Cell Sorter  
(FACS system) Calibur    BD Heidelberg 
Freezer (-20°C) Liebherr Premium   Liebherr, Ochsenhausen 
Freezer (-20°C) Hera Freeze, Kendro  Heraeus, Hanau 
Fridge       Liebherr, Ochsenhausen 
Geldoc2000      Bio-Rad, Munich 
Ice machine      Ziegra, Isernhagen 
Incubators 
CO2 incubators,  Thermo Scientific Forma Thermo, 
Langenselbold 
Incubator with shaker,  Innova 4200 New Brunswick Scientific, USA 
Laminar flow, LaminAir Holten,   Thermo Scientific Thermo, Langenselbold 
Light Cycler PCR, Light cyler 480  
SYBR Green I master    Roche diagnostics, Mannheim, Germany 
Liquid nitrogen tank, Arpege 170   AirLiquide, Langenfeld 
Magnetic stirrer, IKA, Combimag,   RCH Janke& Kunkel AG, Staufen 
Microscope 
Light microscope (cell count),   Axiovert-25 Zeiss, Cologne 
Micropipette plus 
0.2-2 µL, 2-20 µL, 10-100 µL,  
20-200 µL and 100-1000 µL    Thermo Lab Systems 
Multipipette plus     eppendorf, Hamburg 
Nano pure Diamond     Reinstwassersysteme Werner, Barnstedt 
Orbital shaker, MR3000    Heidolph, Schwabach 
pH-meter 766 Calimatic    Knick, Zweibrücken 
Pipette boy,      Accujet Brand, Wertheim 
Rotator, Heidolph Reax-2    Heidolph, Schwabach 
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Scales, Sartorius Laboratories   Sartorius, Heidelberg 
Special accuracy weighing  
machine, Genius     Sartorius, Heidelberg 
Stirred Ultrafiltration Cell (Amicon)   Millipore, Schwabach 
Thermo mixer comfort, heating block  Eppendorf, Hamburg 
Vacuum pump, Model RV3    Edwards, Kruetzwertheim 
Vortex, Genie 2     Scientific Industries, USA 
Water bath, GFL 1086    GFL, Burgwedel 
 
 
6.1.2 Consumables 
Items       Company, Place 
 
 
15ml polypropylene test tubes, CellStar  Greiner Bio-One, Frickenhausen 
50ml polypropylene test tubes, CellStar  Greiner Bio-One, Frickenhausen 
Cannula (sterile) 26G,     Terumo Neolus, Belgium 
20G, 27G      BD microlance3, Spain 
Cell scraper (25 cm)     Sarstedt, Nümbrecht 
Chemotaxis Plates (3 and 5 µm)   Neuro Probe, USA 
Cotton swabs (Q-tips) 
Cover glasses for  
Haemocytometer Superior  Marienfeld Laboratory Glassware, Lauda-
Königshofen 
Cryo vials (sterile) 1.8 ml, CellStar   Greiner Bio-One, Frickenhausen 
Eppendorf tubes, 0.5-2.0 ml    Sarstedt, Nümbrecht 
FACS tubes      BD Falcon, Heidelberg 
Filters (sterile), 0.45 and 0.2 µm   Nunc, Langenselbold 
Microscope slides      Engelbrecht, Edermünde 
Microtitre plates, 96 wells, non sterile  Nunc, Langenselbold 
Neubauer chamber/Haemocytometer  Brand, Wertheim 
Parafilm M      Brand, Wertheim 
Pasteur pipette (230 mm)    Volac, Wertheim 
Transfer pipettes (sterile) 
5,10 and 25 ml     Sarstedt, Nümbrecht 
Sealing tape      Dynex, Frankfurt 
Syringes (sterile) 
1, 5 and 10 ml      BD Falcon, Heidelberg 
Syringes, Micro-fine (sterile),  
1 ml, 29G, U-100     BD Falcon, Heidelberg 
Steriflip, 0.2 µm pore size    Millipore, Schwalbach 
Tissue culture plates 
6-wells, 12-wells and 24-wells   Nunc, Langenselbold 
96-well Fluorlumi white plates  Nunc, Langenselbold 
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Tissue culture flasks     Nunc, Denmark 
Venofix safety     Braun Germany 
 
 
6.1.3 Chemicals and reagents 
Items       Company, Place 
 
 
Acid citrate dextrose (ACD)    Sigma, Steinheim 
Beta galactosidase     Sigma, Seelze, Germany 
BSA (Bovine Serum Albumin fraction V)  Serva, Heidelberg 
BBL Middlebrook ADC enrichment  BD,  Heidelberg, Germany 
C-12 FDG  
(5-Dodecanoylaminofluorescein  
Di-β-D-Galactopyranoside)-    Molecular Probes, Germany 
Calcein AM (0.5 mg/ml DMSO)   Invitrogen, Spain 
Complete protease inhibitor  
Cocktail tablet     Roche, Switzerland 
Centrifuge tubes    Beckman Coulter, USA 
Cytochalasin B     Sigma, Steinheim, Germany 
Dextran-70 (Leuconostoc spp.)   Sigma, Steinheim, Germany 
Difco Middlebrook/H9/7H10 broth   BD, Heidelberg, Germany 
Dimethylsulfoxide (DMSO)    Sigma-Aldrich, Seelze, Germany 
Dimethylformamide (DMF)    Sigma, Seelze, Germany 
DMSO      Sigma, Steinheim 
ECL plus Western blotting  
detection reagents     Amersham, Freiburg, Germany 
Ethanol      Roth, Karlsruhe, Germany 
EDTA (Ethylene diamine tetra  
acetic acid)      Sigma, Steinheim 
FACSRinse, FACSFlow, FACSClean  BD Biosciences, Belgium 
Ficoll       Amersham Bioscience, UK 
Film developer Curix60    Agfa, Cologne 
Fixer and Developer solutions   Agfa, Cologne 
fMLP       Sigma, Steinheim 
Glycerol      Roth, Karlsruhe, Germany 
H2SO4 (96%)     Merck, Darmstadt 
Hank’s balanced salt solution (HBSS) 
Without Ca2+ and Mg2+    Biochrom AG, Berlin 
With Ca2+ and Mg 2+    Biochrom AG, Berlin 
HCL       Roth, Karlsruhe, Germany 
Hepes, 1 M      Gibco, Karlsruhe 
Histopaque-1077    Sigma, Steinheim 
Hybond-P PVDF transfer membrane  Amersham, Freiburg, Germany 
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Hydrogen peroxide (H2O2)    Roth, Karlsruhe 
Hyper film      Amersham, Freiburg, Germany 
Interleukin-8 (IL-8)     R and D Systems, UK 
L-Glutamine      Sigma, Steinheim 
LPS, Ultrapure  
E. coli0111: B4 (TLR4 ligand)   Sigma, Seelze, Germany 
Luminol (3-Aminophthalhydrazide)  Invitrogen, Germany 
Lumiglo reagent     Cell signaling, Frankfurt 
Phorbol myristate acetate    Sigma, Seelze, Germany 
Pre-stained protein marker    Bio-Rad, Munich 
Semi-dry transfer cell    Bio-Rad, Munich 
SDS PAGE gels     Bio-Rad Munich 
SDS PAGE running buffer    Bio-Rad, Munich 
Transfer buffer     Bio-Rad, Munich 
NaCl       Roth, Karlsruhe 
Nitrocellulose membrane    Life Technologies 
NuPAGE Bis-Tris mini gels    Life Technologies 
P38 MAPK inhibitor     Sigma, Seelze, Germany 
Penicillin/Streptomycin (10,000 U)   Biochrom AG, Berlin 
Precision Plus Protein Standards 
Dual Color      Bio-Rad, Germany 
Peroxidase, Horseradish    Calbiochem, Darmstadt, Germany 
SiMAG-Octaecyl (C-18) size 1 µm   Chemicell, Berlin, Germany 
Sodium azide (NaN3)(0.05%)   Fluka, Steinheim 
Sodium Pyruvate, 100 mM     Gibco, Karlsruhe 
Sterifix injection filter 0.2 µm injection  Braun Germany 
Sucrose, Molecular biology grade  Calbiochem, Darmstadt, Germany 
Super oxide dismutase (SOD)   Sigma, Seelze, Germany 
Trypan blue      Sigma, Steinheim 
Tween®20 (Poly oxyethylene  
sorbitanmonolaurate)     Sigma, Steinhein 
XCell II Blot Module     Life technologies 
XCell sure Lock Electrophoresis System  Life technologies 
Zymogen      Sigma, Steinheim 
 
 
6.1.4 Commercial kits used 
Items       Company, Place 
 
Apoptosis Detection Kit     
Annexin V PE conjugated    BD Pharmingen, Heidelberg 
BCA test kit      Pierce, Rockfort, USA 
Duo set ELISA kit     R and D systems, UK 
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IL-1β       R and D systems, UK 
IL-1RA      R and D systems, UK 
IL-6       R and D systems, UK 
IL-8       R and D systems, UK 
IL-10       R and D systems, UK 
TNF-α      R and D systems, UK 
Leukogate (CD45 FITC/CD14 PE)  BD, Heidelberg, Germany 
 
 
 
6.1.5 Antibodies 
 
For Western blotting 
Anti-phospho p38 MAPK (1:1000)   Cell signaling, Frankfurt 
Anti-beta actin (1:3000)    Cell signaling, Frankfurt 
Anti-HSP70 (1:200)     Santa Cruz, Heidelberg, Germany 
Anti-MHC I (1:1000)     Abcam, UK 
Anti-MHC II (1:500)     Abcam, UK 
Anti-CD86 (1:1000)     Santa Cruz, Heidelberg, Germany 
Anti-Rab5 (1:250)     Santa Cruz, Heidelberg, Germany 
Anti-Mouse (HRP-conjugated) (1:5000)  Cell signaling, Frankfurt 
Anti-Rabbit (HRP-conjugated) (1:5000)  Cell signaling, Frankfurt 
 
For degranulation study 
Anti-CD35 (FITC)     BD Pharmingen, Heidelberg 
Anti-CD63 (PE)     BD Pharmingen, Heidelberg 
Anti-CD66b (Alexa 647-APC)   AbDSerotec, Puchheim, Germany 
 
 
6.1.6 Buffers, media and solutions 
 
All buffers and solutions were prepared or diluted with either Nano pure water, sterile aqua 
ad iniectabilia or PBS 
Aqua ad iniectabilia     Delta Select, Pfullingen 
Phosphate buffered saline-  
Dulbecco (PBS)     Biochrom AG, Berlin 
VLE (very low endotoxin)-RPMI  
Roswell Park Memorial Institute  
(1640) medium     Biochrom AG, Berlin 
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Medium	  for	  mycobacteria	  
7H9 broth      Middlebrook 7H9 broth-4.7 g 
Tween 80 (20%)-2.5 ml 
Glycerol-2.5 ml 
Aqua dest. - 895.5 ml 
ADC-100 ml 
 
7H10 agar plates     Middlebrook 7H10 agar-19 g 
Tween 80 (20%)-2.5 ml 
Glycerol-5 ml  
Aqua dest. – 900 ml 
ADC-100 ml 
 
 Cell	  culture	  
 
Fetal Calf Serum (FBS) LPS-free   Heat inactivated before use, 30 min at 56°C 
 
 
THP-1 cell medium     RPMI 1640 
Glutamine-2 mM  
HEPES-10 mM 
Sodium pyruvate-1 mM 
Streptomycin-100 µg/ml 
Penicillin-100 U/ml 
β-mercaptoethanol-0.05 mM 
FCS-10% 
 
TC medium      RPMI medium 
FCS-10% 
 
Freezing medium     FCS-90% 
DMSO-10% 
 
Preparation of samples for Western blotting 
 
Lysis buffer B     Tris (H 6.8)-62.5 mM 
SDS-3% 
β-mercaptoethanol-1.5 % 
Glycerol-8.5% 
Protease inhibitor cocktail tablet (Roche) 
 Western	  blotting	  
 
Bio-Rad XT sample buffer (4x)  Tris-HCl (pH 8.5)-1 M 
(purchased)     SDS-8% 
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Glycerol-40% 
EDTA-2 mM 
Coomassie blue 
Phenol red 
 
 
Transfer buffer 1x     Transfer buffer (NuPAGE) (20x) -25 ml 
Methanol-50 ml 
Antioxidant-500 µL 
Aqua dest. – 500 ml 
 
TBST buffer (Wash buffer)   Tris (pH 7.5)-1 M 
NaCl-150 mM 
Tween 20-0.1% 
 
Antibody dilution and blocking buffer 5% Milk powder in TBST 
 
Neutrophil isolation 
Erythrocyte lysis     NaCl (0.2 and 1.6%) 
 
ROS assay 
2x luminol mix    RPMI medium (w/o phenol red)-12.5 ml 
HRP (400 U/ml in sterile water)-200 µL 
Luminol (5 µM in DMSO)-200 µL 
 
Determination of CFU 
 
2x lysis buffer     Tritonx100-1% 
SDS-0.2% in PBS (cold) sterilized 
for 5 min  
 
WTA serial dilution buffer    Tween 80-1% 
BSA-1% in distilled water (sterilized) 
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6.1.7 Bacterial strains 
Strain Characteristics Source 
 
SCH228  
M. avium hominissuis 
 
Isolated from the bone 
marrow of an AIDS patient 
 
Kindly provided by PD Dr 
Georg Plum, Institute for 
Medical Microbiology, 
Immunology and Hygiene, 
Uniklinik, Cologne 
 
SCH215  
M. avium hominissuis 
 
Isolated from the lymph 
node a five year old boy, 
suffering from cervical 
lymphadenitis 
 
Kindly provided by PD Dr 
Georg Plum, Institute for 
Medical Microbiology, 
Immunology and Hygiene, 
Uniklinik, Cologne 
 
SA 
Staphylococcus aureus 
  
Kindly provided by PD Dr 
Georg Plum, Institute for 
Medical Microbiology, 
Immunology and Hygiene, 
Uniklinik, Cologne 
 
 
6.1.8 Cell lines 
Cell line Characteristics Source 
 
THP-1 
 
Human monocytic cell line 
derived from an acute 
monocytic leukemia patient 
 
ATCC® TIB-202TM 
(Tsuchiya et al., 1980) 
 
6.1.9 Softwares 
Item       Company, Place 
 
Cell Quest pro (FACS-Analysis)   BD, Heidelberg, Germany 
Endnote      Thomson Reuter 
Graph Pad Prism     Prism 
LightCycler 480 Software release  
1.5.0 SP1 version 1.5.0.39 (Plate)   Roche Diagnostics, Mannheim, Germany 
FACS FlowJo 
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6.2 Methods 
6.2.1 Culturing and freezing of THP cell line 
THP-1 (ATCC® TIB-202TM) is a monocyte-like cell line derived from a one-year-old boy 
suffering from monocytic leukemia (Tsuchiya et al., 1980). These cells were grown as cell 
suspension in RPMI medium containing 2 mM L-Glutamine, 10 mM HEPES, 1 mM sodium 
pyruvate, 100 µg/ml streptomycin, 100 U/ml penicillin, 0.05 mM 2-mercaptoethanol and 
10% fetal calf serum (FCS) at 37°C with 5% CO2 in humid atmosphere. To establish the 
culture, 4 x 105 viable cells/ml cells were seeded in 20ml media allowed to grow for 2-3 
days and were sub-cultured at a split ratio 1/4 to 1/5 when the density reaches 1 x 106 
cells/ml.  For cell stocks, the cell pellet was suspended in freezing medium containing 90% 
FCS and 10% DMSO. 1 ml cell suspension was aliquoted in cryo-vial and stored in liquid 
nitrogen.  
 
6.2.2 Differentiation of THP-1 cells to macrophages 
Monocytic THP-1 cells were differentiated to macrophages by PMA treatment. Floating 
monocytic cells were pelleted, suspended in RPMI medium containing 10% FCS and 100 
nM PMA at a concentration of 10 x 106 cells/ml and allowed to differentiate for 1-2 days to 
become adherent macrophages.  
 
6.2.3 Preparation of mycobacterial stock P0 
Mycobacterial strains, SCH228 and 215 which were previously isolated from patients 
materials sent to the IMMIH of the University Cologne for diagnostic investigations, were 
kindly provided by PD Dr Georg Plum. In order to maintain the virulence nature and a lab 
stock of the strains, these mycobacteria were passaged through BALB/c mice. Mice were 
infected intravenously with 1x107 M. avium. After 6-8 weeks, mice were sacrificed, spleens 
and livers were isolated aseptically, their homogenates were aliquoted and frozen at -80°C. 
These organ homogenates were called passage, P0. 
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6.2.4 Preparation of mycobacterial stock P1 
Mycobacteria from organ passage P0 were streaked with an inoculum loop on 7H10 plates 
supplemented with ADC and PANTA, and incubated for 7-10 days. A single colony was 
suspended in sterile PBS and streaked again on several 7H10 agar plates. After another 7-10 
days of incubation, mycobacteria from all the plates were harvested, pooled in 7H9 broth, 
and washed once with PBS by centrifugation at 4600 xg for 10 min. Finally, the pellet 
suspended in PBS was singularized by passing through 20G needle and stored at -80°C as 
100 µL aliquots. An aliquot was used to determine the number of viable mycobacteria 
present in this 100 µL volume by determining colony-forming unit. 
 
6.2.5 Determination of CFU 
Nine hundred µL of PBS was added to the 100 µL mycobacterial aliquot and this suspension 
was singularized through a 20G needle. Ten-fold serial dilutions were made in PBS and 20 
µL of the diluted samples in triplicate were dropped on 7H10 agar. Colony forming units 
(CFUs) were counted after a time period of 7-14 days. CFU of mycobacterial stocks were 
calculated as CFU/ml.  
 
6.2.6 Culturing of human monocyte derived macrophages (HMDM)  
A buffy coat was obtained from a 500ml blood donation of the same day from the University 
clinic blood bank, University of Cologne. The buffy coat was diluted 1:1 with PBS and 25 
ml of the diluted buffy coat was overlaid on 15 ml Histopaque gradient solution. This 
gradient was centrifuged at 1600rpm for 30min without break. After centrifugation, the thin 
interlayer between plasma and RBC, which contains white blood cells and platelets were 
carefully transferred into a fresh 50 ml tube. The isolated cells were then washed twice with 
RPMI by centrifuging at 900 rpm for 10 min. The total number of cells were counted using a 
Neubauer chamber and adjusted to a density of 2x107 cells/ml with RPMI medium 
containing 5% FCS. These cells were plated on human serum opsonized 6-wells or 24-wells 
plates as required. The monocytes were allowed to adhere on to the base overnight at 37°C 
in a 5% CO2 atmosphere. After incubation cells were washed with pre-warmed RPMI 
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medium to remove the non-adherent cells. The adherent cells were allowed to differentiate 
into macrophages for another 5-6 days. Cells were renewed with RPMI medium containing 
10% FCS (TC medium) every second day. The differentiated macrophages were used for 
further experiments. 
 
6.2.7 Growth rate of M. avium (SCH228 and 215) in HMDM 
Six-well plates were seeded with 1x106 monocytes isolated from buffy coat and allowed to 
differentiate into HMDM for 7 days. Macrophages were then infected with SCH 228 and 
215 with a ratio 1:10 at 37°C. The required number of bacteria was calculated and diluted 
from the mycobacterial stock. After 2 h infection, cells were washed thoroughly with warm 
RPMI medium to remove extracellular bacteria, replenished with fresh warm TC medium 
and further incubated at 37°C. At different time points (2, 48 and 72 h) infected cells were 
lysed in lysis buffer for 10min and plated on 7H10 agar plates. 7H10 agar plates were 
incubated at 37°C for 7-10 days for enumerating colony forming units (CFU). The CFU 
count obtained after 2 h was considered as the time zero post infection. The generation time 
of the mycobacteria was calculated by this formula generation time (h) = (time y- time x) / 
3.3LOG (CFUy /CFUx), where, CFU x is the number of bacteria at earlier time whereas, 
CFU y is the number of bacteria at later time.   
 
6.2.8 Neutrophil isolation 
Peripheral blood (20 ml) was collected in 50 ml Perfusor syringe filled with 18 ml Dextran 
70/0.9% NaCl and 2 ml Citrate-Dextrose solution (ACD), mixed gently and allowed to stand 
at RT for RBC to settle. After 1 h of RBC sedimentation, the top clear leukocyte rich plasma 
was overlaid on 15 ml Ficoll in a 50 ml centrifuge tube using a Venofix safety. This gradient 
was centrifuged at 2000 rpm at RT for 20 min without break. After the centrifugation, 
everything was removed except the RBC and neutrophils pellet. RBC present in the pellet 
was lysed by adding first 8 ml of 0.2% NaCl followed by 1.6% NaCl solution, each for 20-
30 sec and washed with HBSS buffer (without Ca2+ and Mg2+) containing 0.1% chicken egg 
albumin by centrifuging at 1000rpm for 5 min with break. After another wash, cells were 
	   93	  
counted using Haemocytometer. The purity of the isolated neutrophils by this method as 
assessed by FACS was over 90%. 
 
6.2.9 Killing of Mycobacteria by human neutrophils 
Bacterial survival in human neutrophils was determined as per Corleis et al. (2012). 
Neutrophils (2.5 x 105 cells) were added to each 1.5 ml centrifuge tube and infected with 
mycobacteria (rato 1:1). After 15 min of infection, cells were centrifuged at 300 xg for 10 
min at RT. The neutrophil pellet was washed with TC medium by centrifugation. After 
another wash, neutrophils were re-suspended in 500 µL of the TC medium. Infected 
neutrophils were further incubated at 37°C. At different time points (1, 2 and 3 h), infected 
cells were lysed with 500 µL of 2x lysis buffer for 5 min. Neutrophil lysates were then 
serially diluted 10-fold in WTA serial dilution buffer, plated on sterile on 7H10 agar plates 
and incubated at 37°C for 7-10 days for enumerating colony forming units (CFU). The CFU 
count obtained after 15 min was considered as the time zero post infection.  
 
6.2.10 Preparation of Zymosan-activated serum 
Blood from healthy donor was collected in the serum collecting tube and serum was 
harvested by centrifuging at 3000 rpm for 5 min at RT. Zymosan was dissolved at 1mg/ml 
concentration in the serum and incubated at 37°C for 30 min before they were heat 
inactivated at 56°C for 30 min. After inactivation, samples were centrifuged at 300 xg for 10 
min and then the clarified supernatant was collected, aliquoted and stored at -20°C. 
 
6.2.11 Chemotaxis assay 
Human neutrophils were isolated from peripheral blood from healthy donors using Dextran-
Ficoll method. Neutrophils suspended in 2 ml HBSS (without Ca2+ and Mg2+) containing 
0.1% chicken egg albumin were stained with the fluorescent dye Calcein AM at 3 µM 
concentration for 20 min at 37°C with gentle shaking and washed twice thereafter with 
HBSS buffer. After cell counting, cells were adjusted to a density of 1 x 107 cells/ml in 
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HBSS buffer (with Ca2+ and Mg2+). Chemoattractant dilutions of different concentrations 
were prepared in HBSS buffer (with Ca2+ and Mg2+) and then carefully, pipetted onto the 
bottom plate (29 µl/well). The filter (3 µm pore size) was gently stacked onto the plate 
before 25µl of cell were pipetted onto the filter. Zymosan activated serum (ZAS; 0.1 mg/ml) 
was used as positive and HBSS buffer as negative control. After 90min of incubation, 
unmigrated neutrophils were removed carefully from the top of the filter and the filter was 
dried gently with Q-tips. Migration of the fluorescent neutrophils from filter to bottom plate 
was quantified by measuring the total fluorescence from plate as well as filter in Tecan. Each 
concentration was pipetted at least in triplicates and the migration assay was performed at 
least three times. 
 
6.2.12 Coating of mycobacteria with C12-FDG 
Coating of mycobacteria was performed according to Robinson et al. (2008). An aliquot of 
mycobacteria (in some experiments, mycobacteria were heat inactivated at 95°C for 20 min) 
washed with PBS by centrifuging at 12000 xg for 5 min at RT. Mycobacteria pellet was 
suspended in 190 µL of 100 mM NaHCO3 buffer (pH 9.6), mixed with 10µL of C12-FDG 
(stock 20 mM) and incubated in sonicator water bath at 37°C for 1 h with intermittent 
sonication for 10 sec every 10 min. After 1h incubation, 800 µL NaHCO3 buffer was added 
and mycobacteria were washed twice by centrifugation. Finally, bacteria were suspended in 
200 µL NaHCO3 buffer. The coating was visualized by incubating with 5-10 µL of β-
galactosidase for 10 min at 37°C under UV trans-illuminator.  
 
6.2.13 Coating of magnetic beads with C12-FDG 
Coating of magnetic beads was done according to Robinson et al. (2008). An aliquot of 
magnetic beads (15 µL) was suspended in 190 µL of 100 mM NaHCO3 buffer (pH 9.6), 
mixed with 10 µL of C12-FDG (stock 20 mM) and incubated in sonicator water bath at 37°C 
for 1h with intermittent sonication for 10sec every 10 min. After 1 h incubation, 800 µL 
NaHCO3 buffer was added and beads were washed twice on magnet. Finally, beads were 
suspended in 200 µL NaHCO3 buffer.  
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6.2.14 Phagosomal maturation study in human neutrophils 
Human neutrophils were isolated from peripheral blood from healthy donors using Dextran-
Ficoll method. Neutrophils were suspended in TC medium at a density 2.5x105 cells well in 
24-wells plate and infected with C12-FDG coated mycobacteria at MOI 10 for 15 min at 
37C. C12-FDG coated magnetic beads were used as positive control for this assay. An 
aliquot of beads was added to cells for 10min before they were washed. After infection, 
neutrophils were harvested, pelleted at 300 xg for 10 min to remove extra cellular bacteria 
and re-suspended in 250 µL of TC medium before seeding in 24-wells plate. At different 
time points (0.5, 1, 2, 3, 4 and 5 h), cells were harvested and fluorescence of C12-FDG was 
measured using FACS. After gating the neutrophil population using Leukogate antibody in 
forward and sideward scatter, cells were analyzed for the fluorescence by FACScan using 
FlowJo software. The results were expressed as histogram for the fluorescence-intensity of 
cells in a population. Experiments were performed a minimum of three times in an 
independent manner. 
 
6.2.15 Phagosomal maturation study in human macrophages 
Twenty four-well plates were seeded with 2.5x105 monocytes isolated from buffy coat and 
allowed to differentiate into HMDM for 7 days. Macrophages were then infected with C12-
FDG coated mycobacteria at ratio 1:10 for 1 h at 37°C. C12-FDG coated magnetic beads 
were used as positive control for this assay. An aliquot of beads was added to cells for 10 
min before they were washed. At different time points (0.5, 1, 2, 3, 4 and 5 h), cells were 
harvested and fluorescence of C12-FDG was measured using FACS. After gating the 
macrophage population using Leukogate antibody in forward and sideward scatter, cells 
were analyzed for the fluorescence by FACScan using FlowJo software.  The results were 
expressed as histogram for the fluorescence-intensity of cells in a population. Experiments 
were performed at least two times in an independent manner. 
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6.2.16 Lysis of samples for Western blotting 
Neutrophils were lysed and samples for western blotting were prepared as mentioned by al-
Shami et al. (1997). To the pelleted neutrophils, boiling lysis buffer B was added, mixed and 
boiled for 7 min. Following the boiling, samples were snap cooled on ice and clear lysate 
was collected after centrifuging at 12000 xg for 10 min.  
 
6.2.17 Western Blot Analysis 
Neutrophils were washed with PBS and pelleted by centrifugation. Pellets were lysed for 
whole cell extraction in lysis buffer B plus inhibitors. Lysates were centrifuged, the 
supernatant was collected and used for protein determination prior to protein sample 
separation on a SDS-PAGE. Protein samples were prepared by mixing with loading dye and 
heating at 95°C for 5 min. Equal amount of protein was loaded on to the SDS gel consisting 
of a 12% resolving gel and a 5% stacking gel. The proteins were electrophoresed in a XCell 
sure Lock Mini-Cell Electrophoresis System and XCell II Blot Module from Invitrogen for 
70-90 min at 120 V. Hybond-PVDF membrane was pre-wetted in 100% methanol for 5s 
followed by in water for 5min and then equilibrated in transfer buffer for 10 min. Care was 
taken not to allow the membrane to dry. The SDS gel was also equilibrated in transfer buffer 
for 10 min. A fibre pad was wetted in transfer buffer and placed on the transfer chamber. 
Over the pad two Whatman3 paper sheets of the size of the gel dipped in transfer buffer was 
placed. The gel was placed upon the stack and the membrane over the gel. The membrane 
and gel were sandwiched with another 2 sheets of whatman3 paper wetted with transfer 
buffer. After closing the chamber, transfer was done at 100 V for 90 min at 4°C. 
 
After the transfer, the membrane was washed with wash buffer and blocked by incubating in 
blocking buffer for 1 h at 37°C on an orbital shaker. Then the membrane was washed three 
times (5 min each wash) with wash buffer at RT. Following the washing step, membrane 
was incubated for over night at 4°C on an orbital shaker with primary antibody diluted 
appropriately in antibody dilution buffer. After three washings, the HRP-linked secondary 
antibody was diluted appropriately in antibody dilution buffer and added to the membrane 
and incubated for 1 h at RT with constant shaking. Then, the membrane was washed three 
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times (5 min each wash) in wash buffer at RT. Membrane was placed on a polythene sheet 
and allowed to react with 1x Lumiglo reagent for 2-5 min. Finally, the membrane was 
exposed to an X-ray film (Hyperfilm) for 5-10 min in a hypercassette in the dark and 
developed in Western Blot Developer machine Curix 60. 
For re-probing the membrane with different antibody, the membrane was stripped with 
stripping buffer at RT for 30 min. After incubation, membrane was washed twice with PBS 
and once with wash buffer, each 5 min. The membrane was blocked in blocking buffer for 1 
h at RT before probing with different antibody.  
 
6.2.18 Degranulation study 
Cell surface expression of CD35, CD63, and CD66b was monitored for assessing 
degranulation of secretory, azurophilic, and specific granules, respectively, by flow 
cytometry (Simard et al., 2010). Heparized blood (5 ml) was overlaid on 5 ml of Histopaque 
1077 and allowed to stand for 45 min at RT. Leucocyte rich supernatant (LRS) from the top 
was transferred to a tube containing 2 ml of HBSS/Hepes buffer (10 mM; pH 7.4). 
Following the count, cell density was adjusted to 5x106 cells/ml concentration (Hartmann et 
al., 2001). For some experiments, human neutrophils were isolated from peripheral blood 
from healthy donors using Dextran-Ficoll method. Cells were incubated with fMLP (10µM) 
or mycobacteria (ratio 1:10) for 5 or 15 min at 37C. Following incubation, cells were 
pelleted at 300 xg for 10 min at RT and suspended in 100 µL of HBSS/Hepes buffer. Cells 
were stained with CD35 FITC (5 µL), CD63 PE (5 µL), CD66b Alexa 647 (APC) (2.5 µL), 
Leukogate CD45/CD14 (5 µL) and 7-AAD (5 µL).  After staining, cells were washed once 
with HBSS/Hepes buffer. After gating the neutrophil population using Leukogate antibody 
in forward and sideward scatter, cells were analyzed for expression of various granule 
specific markers on cell surface by FACScan using FlowJo software. These results were 
expressed as histogram for the fluorescence-intensity of the cells in the gated population. 
Experiments were performed at least time times. For some other experiments, cells were 
pretreated at 37°C with p38 MAPK inhibitor (2 µM) for 30 min or IL-8 (50 pg/ml) for 15 
min before they were infected. 
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To test the effect of cytB/fMLP on degranulation, neutrophils (1x107 cells/ml) suspended in 
RPMI medium supplemented with Hepes (25 mM) were first incubated with cytB (5 µg/ml) 
at 37°C for 5 min followed by 30 min incubation with fMLP (0.1 µM). Unstimulated 
neutrophils incubated for the same time at 37°C was used as the negative control for this 
experiment. To subtract the effect of solvents, corresponding volume of the solvent DMSO 
and DMF was added to the neutrophils and incubated, respectively. Following the 
incubation, cells were pelleted at 300 xg for 10 min at RT and suspended in 500 µL of 
HBSS/Hepes buffer. An aliquot of the cell suspension was stained with CD35 FITC (5 µL), 
CD63 PE (5 µL), CD66b Alexa 647 (APC) (2.5 µL), Leukogate CD45/CD14 (5 µL) and 7-
AAD (5 µL).  After staining, the cells were washed once with the HBSS/Hepes buffer. After 
gating neutrophil population using Leukogate antibody in forward and sideward scatter, cells 
were analyzed for expression of various granule specific markers on cell surface by 
FACScan using FlowJo software. 
 
To study the effect of mycobacteria-infected macrophages on degranulation, macrophages 
(2.5x105  cells per well) in 24-wells plate were infected with mycobacteria (ratio 1:10) for 1 
h at 37°C. After the infection, extra cellular mycobacteria were washed off and freshly 
isolated neutrophils were incubated with either uninfected macrophages or infected 
macrophages in 1:1 ratio. At different incubation times (30, 60 and 120 min), neutrophils 
were pelleted at 300 xg for 10 min at RT and suspended in 100 µL of HBSS/Hepes buffer. 
Cells were stained and analyzed for expression of various granule specific markers on cell 
surface by FACScan using FlowJo software. 
 
6.2.19 Apoptosis assay 
To assess the cell death of mycobacteria infected neutrophils, cells were incubated at 1 x 106 
cells/ml in TC medium with mycobacteria (ratio 1:10) at 37°C for 15 min. After infection, 
neutrophils were pelleted at 300 xg for 10 min at RT, washed, re-suspended in 500 µl of TC 
medium and incubated at 37°C. At different time points (1, 2, 3, 4 and 5 h) cells were 
pelleted, suspended in binding buffer and stained with Annexin V-PE (AV) and 7-AAD for 
10 min at RT, according to the manufacturer’s instructions. Cells were washed and acquired 
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by FACS. After gating viable neutrophil population using Leukogate antibody in forward 
and sideward scatter, cells were analyzed for the Annexin positive cells in the gated 
population by FACScan using FlowJo software. These results were expressed as quadrant 
for the fluorescence-intensity of the cells in the gated population. AV positive cells were 
considered as apoptotic cells and AV + and 7-AAD + cells were considered as late 
apoptotic/necrotic cells.  
 
6.2.20 ROS assay 
Human neutrophils were isolated from peripheral blood from healthy donors using Dextran-
Ficoll method and the cell density was adjusted to 2x106 cells/ml concentration in ROS 
medium. Neutrophils (50 µL) were added to each well in 96-well fluorescence/luminescence 
white plate (Nunc). A hundred µL of luminol mix (2x) was added to each well. ROS 
medium (50 µL) or mycobacteria (ratio 1:50; 50 µL) or fMLP (2 µM; 50 µL) was added and 
immediately measured at Tecan using the program ‘Senthil luminol 72 cycles’ (72 cycles 
with 5 min interval and 100msec integration time). For ROS measurement for the co-
infection experiment, neutrophils were infected alone with mycobacteria (SCH 228 and 215 
(ratio 1:50 and 100), respectively; 50 µL) or together with both mycobacteria. For some 
experiments, an aliquot of p38 MAPK inhibitor (50 µL) was added to the row labeled ‘p38 
MAPK inhibitor’ and incubated at 37°C for 30 min before they were infected with 
mycobacteria. 
 
6.2.21 Cytokine measurements  
Human neutrophils were isolated from peripheral blood from healthy donors using Dextran-
Ficoll method and the cell density was adjusted to 2x107 cells/ml concentration in HBSS 
buffer (with Ca2+ and Mg2+). Equal volume of cells and mycobacteria (ratio 1:50) were 
added into a 1.5 ml micro-centrifuge tube and incubated in a thermo mixer at 37°C with a 
gentle shaking. At different time points (1.5, 2, 4 and 6 h), cells were pelleted and the 
supernatant was transferred to another tube. This supernatant was further centrifuged at 
12000 xg for 10 min at 4°C. The clarified supernatant was then transferred to another fresh 
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tube and frozen at -20°C. The levels of IL-6, 8, 10, IL-1β, TNF-α and IL-1ra present in the 
supernatants of neutrophils were measured using commercially available ELISA kits, 
according to the manufacturer’s instructions. For some experiments, neutrophils were 
pretreated with p38 MAPK inhibitor (2 µM) or fMLP (10 µM) for 30 min at 37°C before 
they were infected or they were infected in the presence of SOD (20 µg/ml) or ROS (H2O2; 
400 nM). 
 
6.2.22 In vitro anti-bacterial assay 
Neutrophils (1x107 cells/ml) suspended in RPMI medium supplemented with Hepes (25 
mM) were first incubated with cytB (5 µg/ml) at 37°C for 5 min followed by 30 min 
incubation with fMLP (0.1 µM) (Standish and Weiser, 2009). Unstimulated neutrophils 
incubated for the same time at 37°C was used as the negative control for this experiment. To 
subtract the effect of solvents, corresponding volume of the solvent DMSO and DMF was 
added to the neutrophils and incubated, respectively. Neutrophils were infected with SA at 
ratio 1:1 or mycobacteria at ratio 1:10 for 30 min at 37°C. Following incubation, cells were 
pelleted at 300xg for 10 min at RT, the supernatant was transferred to another tube and 
centrifuged at 12000 xg for 10 min at RT. The clarified supernatant (100 µL) was added to a 
well in 24-well plate that contained 100 µL of mycobacteria (1x106 CFU/ml) in AMA buffer 
and incubated for 48 h. After incubation, 800 µL of WTA buffer was added serially diluted 
10-fold in WTA serial dilution buffer and 20 µL of the diluted samples in triplicate were 
dropped on 7H10 agar. Colony forming units (CFUs) were counted after a time period of 7-
14 days. For assessing the survival of SA, the clarified supernatant (100 µL) was added to 
100 µL of SA (1x105 CFU/ml) and number of bacteria was enumerated after 2 and 4 h by 
CFU method. 
 
6.2.23 Co-culture experiment 
Macrophages (2.5x107 cells per well) in 24-well plate were infected with mycobacteria at 
MOI 10 for 1 h at 37°C. After infection, extra cellular mycobacteria were washed off, 
infected macrophages were incubated in 1:1 ratio with naïve/unstimulated or LPS-stimulated 
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or infected neutrophils. At 48 and 72 h, after washing off neutrophils, infected macrophages 
were lysed and the number of bacteria was enumerated after 2 and 4 h by CFU method. The 
number of bacteria enumerated from infected macrophages without neutrophils was used as 
control. In some other experiments, infected macrophages were incubated with degranulated 
supernatant from mycobacteria infected neutrophils and CFU was determined after 48 and 
72 h of incubation. 
 
6.2.24 Depletion of exosomes from FCS 
Fetal calf serum (FCS) was thawed and heat inactivated at 56°C for 30 min. Then, FCS was 
centrifuged at 100,000 xg for 16 h at 4°C (Bhatnagar and Schorey, 2007).  After 
centrifugation, the supernatant was pooled, sterile-filtered using 0.2 µm filter and stored at -
20°C. 
 
6.2.25 Exosomes isolation 
Macrophages were infected and exosomes were isolated according to Bhatnagar and Schorey 
(2007) with slight modifications. THP macrophages, cultured in TC medium supplemented 
with 10% exosomes-depleted FCS, were infected with mycobacteria with a ratio 1:40 for 4 h 
and followed by extensive washing to remove extracellular bacteria. As control, 
macrophages were left uninfected. After 72 h, the TC medium was collected and centrifuged 
twice at 300 xg, 10 min to remove whole cells, followed by centrifugation at 1,200 xg for 10 
min to remove any bacilli. The supernatant was centrifuged at 10,000 xg for 30 min. Then, 
the supernatant was centrifuged at 100,000 xg for 1 h at 4°C. The resulting pellet (exosomes) 
was suspended in 2.5 ml of 2.5 M sucrose/HBSS buffer and placed in ultra thin centrifuge 
tube. A dis-continuous sucrose gradient (6 ml of 2 M and 3 ml 0.25 M sucrose/HBSS buffer) 
was layered on top of the exosomes suspension. The gradient was then centrifuged at 
100,000 xg for 16h at 4C. Gradient fractions (7x1 ml) were collected from the top of the 
gradient and fractions 3-5 were pooled, diluted with HBSS buffer, centrifuged at 100,000 xg 
for 1 h at 4°C. The resulting exosomes pellet was re-suspended in HBSS buffer and the 
protein concentration was measured using BCA method as per manufacturer’s instructions. 
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6.2.26 Mass spectrometry 
Digestion  
Samples normalised to 70 µg protein in 20 µl were sonicated three times for 10 s.  2 µl 100 
mM DTT were added and the samples were boiled to 96 °C for 10 min. After cooling down 
to room temperature, cysteines were alkylated with 2 µl 250 mM iodine acetamide. Samples 
were stored for 30 min in the dark at room temperature. Excess iodine acetamide was 
quenched with 0.5 µl 100 mM DTT. 200 µl 8M Urea with 0.1 M TEABC were added and 
the samples were transferred to Amicon Ultra centrifugal filter units (0.5 ml, 10K). Filter 
assisted sample preparation (FASP) with sequential Lys C (0.5 µg) and trypsin (1.75 µg) 
digestion was performed according to (3) with minor modifications: Briefly, 0.1 M TrisHCl 
was replaced by 0.1 M triethylammonium bicarbonate pH 8.5 (TEABC) in all buffers used. 
After digestion the samples were centrifuged and filtrates were collected. 150 µl 5 % 
acetonitrile in water were added to the filter, mixed with the residual sample and the units 
were centrifuged once more. C18 SPE cartridges (Strata-C18, 1 ml, Phenomenex) were 
activated with Methanol, washed with 80 % acetonitrile and equilibrated to 5 % acetonitrile 
in 0.1 M TEABC. Combined filtrates were applied, the cartridge were washed two times 
with 300 µl  5 % acetonitrile in 0.1 M TEABC and the peptides were eluted with 300 µl 80 
% acetonitrile in 0.1 M TEABC. One third (100 µl) of the eluates were dried in a vacuum 
centrifuge and redissolved in 10 µl 0.5 M TEABC for ten minutes at room temperature 
 
iTRAQ labelling  
All reagents were used at room temperature. 70 µl Ethanol were added to the iTRAQ 
reagents (AB Sciex) and 25 µl were used for each sample containing approximately 6  µg 
peptides in 10 µl 0.5 M TEABC pH 8.5. After 2 h in the dark the reaction was quenched 
with 50 µl water and the labelled samples were combined. Volumes were reduced to 
approximately 20 µl in a centrifugal evaporator and 200 µl ultrapure were added. STRATA 
C18 cartridges were used for sample clean up as described above. However, this time, 
TEABC was replaced by 0.1 % formic acid in all steps. Desalted peptides were dried in a 
centrifugal evaporator and resuspended in 40 µl of ACN in 0.1 % formic acid.    
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SCX HPLC 
 
Strong Cation Exchange (SCX) Chromatography was performed on a Biobasic SCX column 
(1 mm x 150 mm, Thermo) installed to an Ettan micro LC system (GE Healthcare) operated 
at a flow rate of 50 µl/min and 214 nm fixed wavelength detection. Buffer A was 25 % 
acetonitrile in 0.1 % formic acid adjusted to pH 3.5 with NaOH. Buffer B was 0.5 M NaCl in 
buffer A. Samples redisolved in 40 µl of 40 % acetonitrile in 0.1 % formic acid were 
injected onto the column equilibrated in buffer A. Peptides were separated using a gradient 
of 0 % B for 1.5 min, 0 % - 10 % B in 4 min and 10% - 80 % B in 8 min. Fractions were 
collected every 60 sec. 6 fractions were dried in a vacuum centrifuge, redissolved in 50 µl 5 
% acetonitrile in 0.1 % TFA and used for subsequent LC-MALDI analysis. 
 
MALDI spotting 
Reversed phase nanoHPLC of SCX fractionated peptides was carried out on an Eksigent 
nanoLC 1D plus system (Axel Semrau GmbH, Sprockhövel, Germany) using a vented 
column setup comprising a 0.1-mm-by-20-mm trapping column and a 0.075-by-200-mm 
analytical column, both packed with ReproSil-Pur C18-AQ, 5 µm (Dr. Maisch, Ammerbuch, 
Germany) and operated at 40 °C. 18 µl sample were aspirated into the sample loop and a 
total of 30 ul was loaded onto the trap column using a flow rate of 6 µl/min. Loading pump 
buffer was 0.1 % TFA. Peptides were eluted with a gradient of 5 % to 35% acetonitrile  in 
0.1% TFA over 70 min and a column flow rate of 300 nl/min. 0.7 mg/ml alpha-Cyano-4-
hydroxycinnamic acid (HCCA) in 95 % acetonitrile in 0.1 % TFA, 1 mM ammonium 
phosphate were fed in using a syringe pump operated at 150 µl/h and a post column T-union. 
384 fractions (10 seconds) were deposited onto a MTB AnchorChip 384-800  MALDI 
target (Bruker Daltonics, Bremen, Germany) using Eksigent MALDI spotter (Axel Semrau 
GmbH, Sprockhövel, Germany). 
 
LC-MALDI MS/MS analysis 
MALDI MS and MS/MS analysis were carried out on an Ultraflextreme  MALDI Tof Tof 
mass spectrometer (Bruker Daltonics) operated with a laser repetition rate of 1 Ghz. The 
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process of data acquisition was controlled by Flexcontrol 3.0 and WarpLC. MALDI MS 
spectra were acquired over a mass range from 700 Da – 4000 Da. Spectra were calibrated 
externally using the Peptide Calibration Standard II (all Bruker Daltonics) on the designated 
target calibration spots. The laser was used with fixed energy setting and 3000 
shots/spectrum were collected from random raster points. Precursor ions with signal to noise 
ratios equal or better than 10 were selected for MS/MS analysis. Identical peaks in adjacent 
spots were measured only once, preferentially from the spot with maximum peak intensity. 
The maximum number of MS/MS spectra per spot was limited to 20. However, this value 
was exceeded if no alternative positions had been available. Peaks appearing on more than 
40 % of all spots were ignored. MS/MS spectra (3500 shots) were acquired with the 
instrument calibration and iTRAQ reporter ions as well as peptide immonium ions were used 
for internal recalibration.  
 
Database searches and analysis of identified proteins 
Daphnia Pulex (Tax ID 6669) entries (32413 sequences, 10481177 residues) were extracted 
from the NCBInr (Release of February 2. 2014). A composite database was generated with 
the Perl script “makeDecoyDB” (Bruker Daltoniks, Bremen, Germany) which added a 
shuffled sequence and a tagged accession number for each entry. The tagged decoy entries 
were used for the calculation of false positive rates in Proteinscape 3.0. Searches were 
submitted via Proteinscape (Bruker Daltoniks, Bremen, Germany) to  MASCOT 2.2 (Matrix 
Science) and the following parameter settings were used for database searches: enzyme 
“trypsin” with 1 missed cleavage; fixed modifications “carbamidomethyl” ,“iTRAQ4plex 
(K)”, “iTRAQ4plex (N-term)”; optional modifications “Methionine oxidation”, 
“iTRAQ4plex (Y)”, “Gln->pyro-Glu (N-term Q)”. The mass tolerance was set to 15 ppm Da 
for MS and 0.8 Da for MS/MS spectra. Protein lists were compiled in Proteinscape. Peptide 
hits were accepted when the ion score exceeded a value of 25. Protein hits required at least 
one peptide hit exceeding a peptide score of 40. Using this set of search parameters, the false 
positive rate was below 0.5 % on the protein level. 
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8 Abbreviations 	  
°C Degree Celsius 
Ab Antibody 
ADC 
Alexa 647 
APC 
Albumin-dextrose-catalase 
A photo-stable fluorescent conjugate 
Allophycocyanin 
Aqua dest. Distilled water 
BCG Bacille Calmette-Guérin 
BM Bone marrow 
BMDM Bone marrow derived macrophage 
BSA Bovine serum albumin 
CD Cluster of differentiation  
CFU Colony forming unit 
Ctrl Control 
DMSO Dimethyl sulfoxide 
DTT Dithiothreitol, 
ECL Enhanced chemiluminescence 
EDTA Ethylenediamine tetra-acetic acid 
ELISA Enzyme-linked immunosorbent assay 
FACS Fluorescence activated cell sorting  
FCS Fetal calf serum 
FITC Fluorescein isothiocyanate 
FSC Forward scatter 
g Gram 
g Gravitational acceleration 
H2O Water 
HEPES 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid  
h Hour 
HRP Horseradish peroxidase 
IFN- γ Interferon gamma 
IL Interleukin 
inf. Infected 
kDa Kilo Dalton 
Kg Kilogram 
L Liter 
LPS Lipopolysaccharide 
M. avium Mycobacterium avium 
M. tuberculosis; Mtb Mycobacterium tuberculosis 
mAb Monoclonal antibody 
MAC Mycobacterium avium complex 
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MgCl2 Magnesium chloride 
MHC Major histocompatibility complex 
min Minute 
ml Milliliter 
MOI Multiplicity of infection 
MΦ Macrophage 
n Number of tests 
NaCl Sodium chloride 
NaOH Sodium hydroxide 
ng Nano gram 
ns Not significant 
ns Non-stimulated 
NTM Non-tuberculous mycobacteria 
OD Optical density 
P/S Penicillin / Streptomycin 
PANTA Polymyxin b, Ampicillin, Nalidixic acid sodium salt,  Trimethoprim, Amphotericin b  
PBS Phosphate buffered saline 
PE Phycoerythrin 
pH defines the acidity or basicity of an aqueous solution 
HRP Horse radish peroxidase 
rpm Rounds per minute 
RPMI Roswell Park Memorial Institute medium 
RT Room temperature 
RT-PCR Real time PCR 
s Second 
SDS-PAGE Sodium dodecyl sulfate polyacrylamide gel  electrophoresis 
SEM Standard error of the mean 
SSC Sideward scatter 
TBST Tris-buffered saline plus Tween-20 
TMB 3,3′, 5,5′-Tetramethylbenzidine 
TNFα Tumor necrosis factor α  
Tris Tris (hydroxymethyl) amino methane 
Tween Polyoxethylene-sorbitan-monolaureate 
U Unit 
ui Non-infected 
v/v Volume per volume 
w/v Weight per volume 
WB Western blot 
β-Me β-mercaptoethanol 
µl/µL Microliter 
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